#Chr	Start	End	Ref	Alt	Gene.refGene	Func.refGene	ExonicFunc.refGene	GeneDetail.refGene	AAChange.refGene	MAX_MAF	MAX_MAF_ReportedDatabase	GIV_Indian_HOM-VAR	GIV_CDFD_HOM-VAR	Zygosity	Depth	QUAL	FILTER	CADD_phred	MIM_disease.refGene	MIM_id.refGene	InterVar_automated	Orphanet_disorder.refGene	Orphanet_association_type.refGene	Trait_association(GWAS).refGene	HPO_id.refGene	HPO_name.refGene	CLNDN	CLNREVSTAT	CLNSIG	Tissue_specificity(Uniprot).refGene	SIFT_pred	SIFT4G_pred	Polyphen2_HDIV_pred	Polyphen2_HVAR_pred	LRT_pred	MutationTaster_pred	MutationAssessor_pred	FATHMM_pred	PROVEAN_pred	MetaSVM_pred	MetaLR_pred	MetaRNN_pred	M-CAP_pred	PrimateAI_pred	DEOGEN2_pred	BayesDel_addAF_pred	ClinPred_pred	LIST-S2_pred	Aloft_pred	fathmm-MKL_coding_pred	fathmm-XF_coding_pred	Interpro_domain	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Gene damage prediction (all Mendelian disease-causing genes).refGene	Gene damage prediction (Mendelian AD disease-causing genes).refGene	Gene damage prediction (Mendelian AR disease-causing genes).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	LoFtool_score.refGene	Essential_gene.refGene	Essential_gene_CRISPR.refGene	Essential_gene_CRISPR2.refGene	Essential_gene_gene-trap.refGene	Gene_indispensability_score.refGene	Gene_indispensability_pred.refGene	MGI_mouse_gene.refGene	MGI_mouse_phenotype.refGene	ZFIN_zebrafish_gene.refGene	ZFIN_zebrafish_structure.refGene	ZFIN_zebrafish_phenotype_quality.refGene	ZFIN_zebrafish_phenotype_tag.refGene	GnomAdExome_AF	GnomAdExome_AF_popmax	GnomAdExome_controls_AF_popmax	GnomAdGenome_AF	GnomAdGenomeAF_popmax	1000g2015aug_all	esp6500siv2_all	Kaviar_AF	abraom_freq	abraom_filter	GME_AF_popmax	GIV_Indian_AAF	GIV_Indian_HET	GIV_CDFD_AAF	GIV_CDFD_HET	#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	LIB4									
chr5	74685445	74685445	T	C	HEXB	exonic	nonsynonymous SNV	.	HEXB:NM_000521:exon1:c.T185C:p.L62S	1.0	GnomAdGenome_AF_eas	791.0	137.0	hom	148	4123.06	PASS	10.70	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	Benign	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	Sandhoff_disease|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	T	T	.	.	N	P	.	T	N	T	T	T	.	T	.	T	T	.	.;	N	N	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.9714	0.9998	0.9998	0.9723	1.0	0.98143	0.9693	0.0048059	0.964696	PASS	1.0	0.973	45.0	0.982394	5.0	chr5	74685445	.	T	C	4123.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.86;AS_ReadPosRankSum=.;AS_SOR=0.693;DP=157;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.86;SOR=0.693	GT:AD:DP:GQ:PL	1/1:0,148:148:99:4137,440,0
chr5	74689709	74689709	T	C	HEXB	intronic	.	.	.	0.95	GnomAdGenome_AF_ami	125.0	NA	hom	564	16191.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.9039	0.95	0.873802	0.0	0.0002689	0.861809	PASS	0.0	0.862	31.0			chr5	74689709	.	T	C	16191.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.71;AS_ReadPosRankSum=.;AS_SOR=0.759;DP=578;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.71;SOR=0.759	GT:AD:DP:GQ:PL	1/1:0,564:564:99:16205,1686,0
chr5	74690011	74690011	T	-	HEXB	intronic	.	.	.	0.95	GnomAdGenome_AF_ami	NA	NA	hom	504	16427.0	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.904	0.95	0.873802	0.0	0.000461	0.0		0.0					chr5	74690010	.	CT	C	16427.0	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=32.59;AS_ReadPosRankSum=.;AS_SOR=0.837;DP=553;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=32.59;SOR=0.837	GT:AD:DP:GQ:PL	1/1:0,504:504:99:16441,1516,0
chr5	74690650	74690677	AAAAAAAAAAAAAAAAAAAAAAAAAAAA	-	HEXB	intronic	.	.	.	0.0091	GnomAdGenome_AF_sas	NA	NA	het	104	2351.02	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.0014	0.0091	0.0	0.0	0.0001153	0.0		0.0					chr5	74690649	.	CAAAAAAAAAAAAAAAAAAAAAAAAAAAA	C	2351.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.5;AS_FS=1.413;AS_MQ=59.47;AS_MQRankSum=1.6;AS_QD=10.66;AS_ReadPosRankSum=1;AS_SOR=1.051;BaseQRankSum=-1.492;DP=269;ExcessHet=3.0103;FS=1.309;MLEAC=1;MLEAF=0.5;MQ=59.55;MQRankSum=2.57;QD=31.82;ReadPosRankSum=1.26;SOR=1.042	GT:AD:DP:GQ:PL	1/0:11,33:104:99:2368,193,871
chr5	74690650	74690675	AAAAAAAAAAAAAAAAAAAAAAAAAA	-	HEXB	intronic	.	.	.	0.3462	GnomAdGenome_AF_asj	NA	NA	het	104	2351.02	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.2903	0.3462	0.0	0.0	0.0	0.0		0.0					chr5	74690649	.	CAAAAAAAAAAAAAAAAAAAAAAAAAA	C	2351.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.4;AS_FS=15.079;AS_MQ=58.7;AS_MQRankSum=0.7;AS_QD=7.63;AS_ReadPosRankSum=1.4;AS_SOR=4.351;BaseQRankSum=-1.492;DP=269;ExcessHet=3.0103;FS=1.309;MLEAC=1;MLEAF=0.5;MQ=59.55;MQRankSum=2.57;QD=31.82;ReadPosRankSum=1.26;SOR=1.042	GT:AD:DP:GQ:PL	0/1:11,13:104:99:2368,1074,1069
chr5	74690823	74690823	A	G	HEXB	intronic	.	.	.	0.66	GnomAdGenome_AF_ami	NA	NA	hom	525	15457.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.5448	0.66	0.52516	0.0	0.564123	0.0		0.0					chr5	74690823	.	A	G	15457.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.44;AS_ReadPosRankSum=.;AS_SOR=0.736;DP=539;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.44;SOR=0.736	GT:AD:DP:GQ:PL	1/1:0,525:525:99:15471,1573,0
chr5	74691223	74691223	C	T	HEXB	intronic	.	.	.	0.583	GnomAdGenome_AF_fin	NA	NA	hom	546	15796.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.4541	0.583	0.388978	0.0	0.485285	0.0		0.0					chr5	74691223	.	C	T	15796.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.93;AS_ReadPosRankSum=.;AS_SOR=0.7;DP=566;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.93;SOR=0.7	GT:AD:DP:GQ:PL	1/1:0,546:546:99:15810,1633,0
chr5	74692335	74692335	A	-	HEXB	intronic	.	.	.	0.153	GnomAdGenome_AF_afr	NA	NA	het	242	1603.6	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.0582	0.153	0.0	0.0	0.0009989	0.0		0.0					chr5	74692334	.	CA	C	1603.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.2;AS_FS=4.663;AS_MQ=55.87;AS_MQRankSum=0.4;AS_QD=3.69;AS_ReadPosRankSum=0;AS_SOR=0.36;BaseQRankSum=1.32;DP=343;ExcessHet=3.0103;FS=4.157;MLEAC=1;MLEAF=0.5;MQ=59.43;MQRankSum=1.02;QD=8.86;ReadPosRankSum=-0.357;SOR=0.422	GT:AD:DP:GQ:PL	0/1:97,84:242:99:1611,0,1132
chr5	74693472	74693472	C	T	HEXB	intronic	.	.	.	0.95	GnomAdGenome_AF_ami	136.0	NA	hom	603	17063.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.9076	0.95	0.873003	0.0	0.893576	0.875822	PASS	0.0	0.857	28.0			chr5	74693472	.	C	T	17063.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.3;AS_ReadPosRankSum=.;AS_SOR=0.751;DP=615;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.3;SOR=0.751	GT:AD:DP:GQ:PL	1/1:0,603:603:99:17077,1796,0
chr5	74694811	74694811	A	-	HEXB	intronic	.	.	.	0.0007	GnomAdGenome_AF_sas	NA	NA	het	471	260.6	QD2	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	5.767e-05	0.0007	0.0	0.0	0.0001153	0.0		0.0					chr5	74694810	.	CA	C	260.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.5;AS_FS=0.784;AS_MQ=60;AS_MQRankSum=0.6;AS_QD=0.59;AS_ReadPosRankSum=-1.3;AS_SOR=0.779;BaseQRankSum=-0.08;DP=529;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.88;MQRankSum=0.847;QD=0.59;ReadPosRankSum=-1.359;SOR=0.767	GT:AD:DP:GQ:PL	0/1:381,59:471:99:268,0,10068
chr5	74695202	74695203	TT	-	HEXB	intronic	.	.	.	0.0002	GnomAdGenome_AF_fin	NA	NA	het	103	286.6	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	3.693e-05	0.0002	0.0	0.0	0.0	0.0		0.0					chr5	74695201	.	CTT	C	286.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=10.492;AS_MQ=60;AS_MQRankSum=0.7;AS_QD=1.66;AS_ReadPosRankSum=-1;AS_SOR=0.04;BaseQRankSum=-1.651;DP=219;ExcessHet=3.0103;FS=15.548;MLEAC=1;MLEAF=0.5;MQ=59.49;MQRankSum=0.429;QD=6.1;ReadPosRankSum=-0.666;SOR=0.05	GT:AD:DP:GQ:PL	0/1:32,15:103:99:294,0,1973
chr5	74695360	74695360	C	T	HEXB	intronic	.	.	.	0.5546	GnomAdGenome_AF_fin	NA	NA	hom	453	12732.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.4408	0.5546	0.378794	0.0	0.0001153	0.0		0.0					chr5	74695360	.	C	T	12732.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=59.39;AS_MQRankSum=.;AS_QD=28.11;AS_ReadPosRankSum=.;AS_SOR=0.839;DP=465;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.31;QD=28.11;SOR=0.839	GT:AD:DP:GQ:PL	1/1:0,453:453:99:12746,1349,0
chr5	74695583	74695583	G	C	HEXB	intronic	.	.	.	1.0	GnomAdGenome_AF_ami	NA	NA	hom	474	12839.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.9999	1.0	0.9998	0.0	0.880821	0.0		0.0					chr5	74695583	.	G	C	12839.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.4;AS_FS=3.235;AS_MQ=59.88;AS_MQRankSum=4.7;AS_QD=27.09;AS_ReadPosRankSum=0.4;AS_SOR=0.599;BaseQRankSum=0.491;DP=492;ExcessHet=3.0103;FS=3.235;MLEAC=2;MLEAF=1;MQ=59.83;MQRankSum=4.74;QD=27.09;ReadPosRankSum=0.435;SOR=0.599	GT:AD:DP:GQ:PL	1/1:5,469:474:99:12853,1283,0
chr5	74695839	74695839	-	A	HEXB	intronic	.	.	.	0.7757	GnomAdGenome_AF_ami	NA	NA	het	274	1451.6	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.6655	0.7757	0.0	0.0	0.0001537	0.0		0.0					chr5	74695839	.	T	TA	1451.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.7;AS_FS=1.211;AS_MQ=59.58;AS_MQRankSum=-1.1;AS_QD=6.58;AS_ReadPosRankSum=1.1;AS_SOR=0.804;BaseQRankSum=-1.447;DP=370;ExcessHet=3.0103;FS=1.002;MLEAC=1;MLEAF=0.5;MQ=59.64;MQRankSum=-1.58;QD=8.74;ReadPosRankSum=0.816;SOR=0.609	GT:AD:DP:GQ:PL	0/1:85,81:274:99:1459,0,1880
chr5	74696386	74696386	G	C	HEXB	intronic	.	.	.	0.0007	GnomAdGenome_AF_sas	NA	NA	hom	605	17418.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	2.095e-05	0.0007	0.0	0.0	0.0	0.0		0.0					chr5	74696386	.	G	C	17418.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.79;AS_ReadPosRankSum=.;AS_SOR=0.765;DP=632;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.79;SOR=0.765	GT:AD:DP:GQ:PL	1/1:0,605:605:99:17432,1804,0
chr5	74696581	74696581	T	G	HEXB	intronic	.	.	.	0.6585	GnomAdGenome_AF_ami	50.0	64.0	hom	556	15379.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	Sandhoff_disease|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.5177	0.6585	0.492212	0.0	0.0001153	0.522277	PASS	0.0	0.532	16.0	0.690476	46.0	chr5	74696581	.	T	G	15379.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.66;AS_ReadPosRankSum=.;AS_SOR=0.73;DP=567;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.66;SOR=0.73	GT:AD:DP:GQ:PL	1/1:0,556:556:99:15393,1661,0
chr5	74696784	74696784	G	A	HEXB	intronic	.	.	.	0.95	GnomAdGenome_AF_ami	648.0	118.0	hom	461	13788.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	Sandhoff_disease|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.8899	0.9267	0.928	0.8905	0.95	0.853435	0.9005	0.0001153	0.866174	PASS	0.0	0.887	165.0	0.911972	23.0	chr5	74696784	.	G	A	13788.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.91;AS_ReadPosRankSum=.;AS_SOR=0.724;DP=483;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.91;SOR=0.724	GT:AD:DP:GQ:PL	1/1:0,461:461:99:13802,1381,0
chr5	74705092	74705094	AAA	-	HEXB	intronic	.	.	.	0.420635	abraom_freq	7.0	1.0	het	245	4571.02	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.0078	0.0224	0.0	0.0	0.0001153	0.420635	PASS	0.0	0.124	8.0	0.139344	15.0	chr5	74705091	.	CAAA	C	4571.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=2.202;AS_MQ=53.08;AS_MQRankSum=0;AS_QD=9.26;AS_ReadPosRankSum=0.7;AS_SOR=0.446;BaseQRankSum=1.54;DP=463;ExcessHet=3.0103;FS=2.006;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=-0.321;QD=22.63;ReadPosRankSum=1.27;SOR=0.446	GT:AD:DP:GQ:PL	1/0:48,69:245:99:4588,1169,2725
chr5	74705092	74705092	A	-	HEXB	intronic	.	.	.	0.7045	GnomAdGenome_AF_fin	21.0	8.0	het	245	4571.02	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.5031	0.7045	0.658946	0.0	0.0033041	0.533784	PASS	0.0	0.315	14.0	0.237705	13.0	chr5	74705091	.	CA	C	4571.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=3.544;AS_MQ=53.84;AS_MQRankSum=-0.5;AS_QD=8.71;AS_ReadPosRankSum=1.3;AS_SOR=0.636;BaseQRankSum=1.54;DP=463;ExcessHet=3.0103;FS=2.006;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=-0.321;QD=22.63;ReadPosRankSum=1.27;SOR=0.446	GT:AD:DP:GQ:PL	0/1:48,85:245:99:4588,2042,2187
chr5	74705792	74705792	T	C	HEXB	intronic	.	.	.	0.0728	GnomAdGenome_AF_sas	NA	NA	hom	564	14984.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.0284	0.0728	0.0389377	0.0	0.0261641	0.0		0.0					chr5	74705792	.	T	C	14984.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=-1.7;AS_FS=0;AS_MQ=59.99;AS_MQRankSum=0;AS_QD=26.57;AS_ReadPosRankSum=-1.1;AS_SOR=0.672;BaseQRankSum=-1.684;DP=573;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=59.99;MQRankSum=0;QD=26.57;ReadPosRankSum=-1.029;SOR=0.672	GT:AD:DP:GQ:PL	1/1:1,563:564:99:14998,1650,0
chr5	74715577	74715577	C	A	HEXB	exonic	nonsynonymous SNV	.	HEXB:NM_000521:exon8:c.C969A:p.N323K,HEXB:NM_001292004:exon8:c.C294A:p.N98K	3.266e-05	GnomAdExome_AF_sas	NA	NA	hom	515	14923.1	PASS	24.3	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	Uncertain significance	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	D	D	.	.	D	D	.	D	D	D	D	D	D	T	D	D	D	D	.;.;	D	D	Glycoside hydrolase family 20, catalytic domain;.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	3.977e-06	3.266e-05	6.373e-05	0.0	0.0	0.0	0.0	6.5e-06	0.0		0.0					chr5	74715577	.	C	A	14923.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=2.5;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.98;AS_ReadPosRankSum=1.1;AS_SOR=0.211;BaseQRankSum=2.57;DP=522;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.98;ReadPosRankSum=1.17;SOR=0.211	GT:AD:DP:GQ:PL	1/1:2,513:515:99:14937,1520,0
chr5	74715717	74715717	A	-	HEXB	intronic	.	.	.	0.2639	GnomAdExome_AF_asj	1.0	0.0	het	363	1220.6	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.2039	0.2563	0.2548	0.0027	0.014	0.0	0.0	0.0001921	0.066116	PASS	0.0	0.173	163.0	0.152672	40.0	chr5	74715716	.	TA	T	1220.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.9;AS_FS=4.522;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.8;AS_ReadPosRankSum=1.3;AS_SOR=1.004;BaseQRankSum=2.4;DP=475;ExcessHet=3.0103;FS=2.3;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=4.47;ReadPosRankSum=2.31;SOR=0.819	GT:AD:DP:GQ:PL	0/1:182,91:363:99:1228,0,4503
chr5	74716017	74716018	AA	-	HEXB	intronic	.	.	.	0.1051	GnomAdGenome_AF_afr	NA	NA	het	179	1527.6	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.0362	0.1051	0.0	0.0	0.0	0.0		0.0					chr5	74716016	.	CAA	C	1527.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.5;AS_FS=0;AS_MQ=59.44;AS_MQRankSum=1.5;AS_QD=3.32;AS_ReadPosRankSum=1.5;AS_SOR=0.649;BaseQRankSum=-0.243;DP=328;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.32;MQRankSum=1.66;QD=16.08;ReadPosRankSum=1.84;SOR=0.623	GT:AD:DP:GQ:PL	0/1:43,52:179:99:1535,0,1199
chr5	74717786	74717786	A	G	HEXB	intronic	.	.	.	0.8888	GnomAdGenome_AF_afr	NA	NA	hom	545	15675.1	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.8155	0.8888	0.767971	0.0	0.76994	0.0		0.0					chr5	74717786	.	A	G	15675.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.76;AS_ReadPosRankSum=.;AS_SOR=0.734;DP=557;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.76;SOR=0.734	GT:AD:DP:GQ:PL	1/1:0,545:545:99:15689,1627,0
chr5	74719941	74719941	A	-	HEXB	intronic	.	.	.	0.1729	GnomAdGenome_AF_afr	NA	NA	het	246	775.6	PASS	.	[MIM:268800]GM2-gangliosidosis 2 [recessive?];	606873	.	Sandhoff disease, infantile form;Sandhoff disease, adult form;Sandhoff disease, juvenile form	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Night sleep phenotypes[27126917];	HP:0000158;HP:0007272;HP:0010729;HP:0002574;HP:0002493;HP:0000007;HP:0000618;HP:0000966;HP:0000256;HP:0000975;HP:0001251;HP:0001347;HP:0001324;HP:0004343;HP:0001260;HP:0002380;HP:0001640;HP:0003202;HP:0006901;HP:0000802;HP:0001433;HP:0002028;HP:0000020;HP:0000280;HP:0001278	Macroglossia;Progressive psychomotor deterioration;Cherry red spot of the macula;Episodic abdominal pain;Upper motor neuron dysfunction;Autosomal recessive inheritance;Blindness;Hypohidrosis;Macrocephaly;Hyperhidrosis;Ataxia;Hyperreflexia;Muscle weakness;Abnormality of glycosphingolipid metabolism;Dysarthria;Fasciculations;Cardiomegaly;Skeletal muscle atrophy;Impaired thermal sensitivity;Impotence;Hepatosplenomegaly;Chronic diarrhea;Urinary incontinence;Coarse facial features;Orthostatic hypotension	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;alveolus;spinal ganglion;smooth muscle;skin;stomach;unclassifiable (Anatomical System);amniotic fluid;larynx;kidney;uterus;retina;pancreas;muscle;head and neck;mammary gland;mesenchyma;islets of Langerhans;visual apparatus;cervix;fovea centralis;vein;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;duodenum;trabecular meshwork;lung;salivary gland;ovary;thyroid;macula lutea;lymph node;bladder;colon;placenta;prostate;breast;	superior cervical ganglion;placenta;	3.71E-01	N	N	N	N	0.666915489058758	E	Hexb	immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	hexb	intersegmental vessel	morphology	abnormal	0.0	0.0	0.0	0.0533	0.1729	0.0	0.0	0.0001921	0.0		0.0					chr5	74719940	.	CA	C	775.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.2;AS_FS=2.773;AS_MQ=59.18;AS_MQRankSum=-2.3;AS_QD=3.96;AS_ReadPosRankSum=-0.4;AS_SOR=0.919;BaseQRankSum=-0.252;DP=316;ExcessHet=3.0103;FS=5.335;MLEAC=1;MLEAF=0.5;MQ=59.69;MQRankSum=-1.685;QD=3.96;ReadPosRankSum=-0.384;SOR=1.035	GT:AD:DP:GQ:PL	0/1:141,55:246:99:783,0,3565
chr5	78777852	78777852	A	-	ARSB	UTR3	.	NM_000046:c.*2545delT	.	0.0599	GnomAdGenome_AF_eas	NA	NA	het	368	2120.6	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0107	0.0599	0.0	0.0	0.0001153	0.0		0.0					chr5	78777851	.	CA	C	2120.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.8;AS_FS=1.043;AS_MQ=59.18;AS_MQRankSum=-0.6;AS_QD=2.53;AS_ReadPosRankSum=1.1;AS_SOR=0.79;BaseQRankSum=1.4;DP=512;ExcessHet=3.0103;FS=2.476;MLEAC=1;MLEAF=0.5;MQ=59.05;MQRankSum=-0.569;QD=9.3;ReadPosRankSum=1.38;SOR=0.564	GT:AD:DP:GQ:PL	0/1:112,116:368:99:2128,0,2046
chr5	78777989	78777989	T	C	ARSB	UTR3	.	NM_000046:c.*2408A>G	.	0.02439	abraom_freq	NA	NA	hom	694	20612.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6	criteria_provided,_single_submitter	Uncertain_significance	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.005	0.0102	0.00419329	0.0	0.0058399	0.02439	LowQual	0.0					chr5	78777989	.	T	C	20612.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.7;AS_ReadPosRankSum=.;AS_SOR=0.828;DP=725;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.7;SOR=0.828	GT:AD:DP:GQ:PL	1/1:0,694:694:99:20626,2073,0
chr5	78780445	78780446	GT	-	ARSB	exonic	frameshift deletion	.	ARSB:NM_000046:exon8:c.1553_1554del:p.D518Afs*4	0.0	GnomAdExome_AF	NA	NA	hom	698	30692.0	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr5	78780444	.	GGT	G	30692.0	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.66;AS_ReadPosRankSum=.;AS_SOR=0.74;DP=720;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=30.74;SOR=0.74	GT:AD:DP:GQ:PL	1/1:0,698:698:99:30706,2098,0
chr5	78781323	78781323	-	TT	ARSB	intronic	.	.	.	0.1555	GnomAdGenome_AF_afr	NA	NA	het	100	87.6	QD2	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0725	0.1555	0.0	0.0	0.0683879	0.0		0.0					chr5	78781323	.	C	CTT	87.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=0;AS_MQ=22.16;AS_MQRankSum=0.4;AS_QD=1;AS_ReadPosRankSum=-0.3;AS_SOR=0.114;BaseQRankSum=-1.869;DP=417;ExcessHet=3.0103;FS=14.259;MLEAC=1;MLEAF=0.5;MQ=58.95;MQRankSum=0.783;QD=1;ReadPosRankSum=-0.087;SOR=0.024	GT:AD:DP:GQ:PL	0/1:66,22:100:95:95,0,1567
chr5	78839378	78839378	C	T	ARSB	exonic	synonymous SNV	.	ARSB:NM_000046:exon6:c.G1191A:p.P397P,ARSB:NM_198709:exon7:c.G1191A:p.P397P	0.5186	GnomAdExome_AF_afr	46.0	5.0	hom	437	13416.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	Benign	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.1901	0.5186	0.5225	0.2691	0.4981	0.259185	0.2918	0.19959	0.247947	PASS	0.39899	0.226	286.0	0.204225	48.0	chr5	78839378	.	C	T	13416.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.8;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=30.7;AS_ReadPosRankSum=0;AS_SOR=1.014;BaseQRankSum=0.858;DP=445;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=30.7;ReadPosRankSum=0.083;SOR=1.014	GT:AD:DP:GQ:PL	1/1:1,436:437:99:13430,1285,0
chr5	78885600	78885600	C	T	ARSB	exonic	nonsynonymous SNV	.	ARSB:NM_000046:exon5:c.G1126A:p.V376M,ARSB:NM_198709:exon6:c.G1126A:p.V376M	0.2553	GnomAdGenome_AF_asj	29.0	5.0	hom	307	9182.06	PASS	14.45	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	T	T	P	B	N	P	L	D	N	T	T	T	.	T	T	T	T	T	.;.;.;	D	N	.;.;.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.1526	0.2038	0.2047	0.1348	0.2553	0.108626	0.137	0.147262	0.178161	PASS	0.25	0.184	249.0	0.197183	46.0	chr5	78885600	.	C	T	9182.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.91;AS_ReadPosRankSum=.;AS_SOR=1.046;DP=319;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.91;SOR=1.046	GT:AD:DP:GQ:PL	1/1:0,307:307:99:9196,917,0
chr5	78955688	78955688	C	T	ARSB	intronic	.	.	.	0.2344	GnomAdGenome_AF_ami	7.0	NA	hom	454	12824.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1344	0.2344	0.116014	0.0	0.155294	0.167742	PASS	0.0	0.092	7.0			chr5	78955688	.	C	T	12824.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=-1.3;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.25;AS_ReadPosRankSum=0.9;AS_SOR=0.606;BaseQRankSum=-1.285;DP=458;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.25;ReadPosRankSum=0.978;SOR=0.606	GT:AD:DP:GQ:PL	1/1:1,453:454:99:12838,1322,0
chr5	78964857	78964857	T	-	ARSB	intronic	.	.	.	0.4673	GnomAdGenome_AF_afr	3.0	NA	het	448	1050.6	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2713	0.4673	0.29353	0.0	0.0089326	0.293375	PASS	0.0	0.049	1.0			chr5	78964856	.	GT	G	1050.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0;AS_FS=0.651;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.6;AS_ReadPosRankSum=1.1;AS_SOR=0.788;BaseQRankSum=0.594;DP=520;ExcessHet=3.0103;FS=0.58;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.59;ReadPosRankSum=1.21;SOR=0.602	GT:AD:DP:GQ:PL	0/1:321,84:448:99:1058,0,8356
chr5	78965194	78965194	T	G	ARSB	intronic	.	.	.	0.4411	GnomAdGenome_AF_ami	NA	NA	hom	491	14052.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2892	0.4411	0.230431	0.0	0.320463	0.0		0.0					chr5	78965194	.	T	G	14052.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.62;AS_ReadPosRankSum=.;AS_SOR=0.722;DP=494;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.62;SOR=0.722	GT:AD:DP:GQ:PL	1/1:0,491:491:99:14066,1467,0
chr5	78966245	78966245	A	C	ARSB	intronic	.	.	.	0.2344	GnomAdGenome_AF_ami	NA	NA	hom	558	15687.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1402	0.2344	0.118211	0.0	0.159059	0.0		0.0					chr5	78966245	.	A	C	15687.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.11;AS_ReadPosRankSum=.;AS_SOR=0.79;DP=572;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.11;SOR=0.79	GT:AD:DP:GQ:PL	1/1:0,558:558:99:15701,1663,0
chr5	78966729	78966729	C	A	ARSB	intronic	.	.	.	0.8654	GnomAdGenome_AF_asj	NA	NA	hom	540	15921.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.813	0.8654	0.760982	0.0	0.0001537	0.0		0.0					chr5	78966729	.	C	A	15921.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.48;AS_ReadPosRankSum=.;AS_SOR=0.852;DP=567;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.48;SOR=0.852	GT:AD:DP:GQ:PL	1/1:0,540:540:99:15935,1615,0
chr5	78966927	78966928	AA	-	ARSB	intronic	.	.	.	0.0068	GnomAdGenome_AF_fin	NA	NA	het	261	4811.02	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0017	0.0068	0.0	0.0	0.0001153	0.0		0.0					chr5	78966926	.	TAA	T	4811.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.5;AS_FS=4.671;AS_MQ=59.24;AS_MQRankSum=0;AS_QD=7.2;AS_ReadPosRankSum=-0.5;AS_SOR=0.325;BaseQRankSum=0.194;DP=342;ExcessHet=3.0103;FS=5.474;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.69;ReadPosRankSum=-0.173;SOR=0.342	GT:AD:DP:GQ:PL	1/0:24,79:261:99:4828,1579,2026
chr5	78966927	78966927	A	-	ARSB	intronic	.	.	.	0.6906	GnomAdGenome_AF_asj	NA	NA	het	261	4811.02	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.5742	0.6906	0.288738	0.0	0.0001153	0.0		0.0					chr5	78966926	.	TA	T	4811.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.2;AS_FS=1.963;AS_MQ=58.33;AS_MQRankSum=0;AS_QD=11.8;AS_ReadPosRankSum=0.1;AS_SOR=0.448;BaseQRankSum=0.194;DP=342;ExcessHet=3.0103;FS=5.474;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=22.69;ReadPosRankSum=-0.173;SOR=0.342	GT:AD:DP:GQ:PL	0/1:24,109:261:99:4828,1767,1647
chr5	78967190	78967190	G	A	ARSB	intronic	.	.	.	0.4411	GnomAdGenome_AF_ami	NA	NA	hom	584	17003.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.3	0.4411	0.241414	0.0	0.325073	0.0		0.0					chr5	78967190	.	G	A	17003.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.11;AS_ReadPosRankSum=.;AS_SOR=0.742;DP=596;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.11;SOR=0.742	GT:AD:DP:GQ:PL	1/1:0,584:584:99:17017,1745,0
chr5	78967674	78967674	A	-	ARSB	intronic	.	.	.	0.5056	GnomAdGenome_AF_fin	NA	NA	het	299	2183.6	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.4379	0.5056	0.367013	0.0	0.0008068	0.0		0.0					chr5	78967673	.	TA	T	2183.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1;AS_FS=0.503;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.73;AS_ReadPosRankSum=-1;AS_SOR=0.753;BaseQRankSum=-0.583;DP=357;ExcessHet=3.0103;FS=0.909;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=0;QD=10.35;ReadPosRankSum=0.308;SOR=0.758	GT:AD:DP:GQ:PL	0/1:110,101:299:99:2191,0,2309
chr5	78968316	78968321	TTATTA	-	ARSB	intronic	.	.	.	0.2291	GnomAdGenome_AF_fin	NA	NA	het	280	9236.02	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1453	0.2291	0.0	0.0	0.0001921	0.0		0.0					chr5	78968315	.	TTTATTA	T	9236.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.6;AS_FS=4.865;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.63;AS_ReadPosRankSum=-0.1;AS_SOR=0.223;BaseQRankSum=-1.23;DP=367;ExcessHet=3.0103;FS=11.471;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=-0.231;QD=32.99;ReadPosRankSum=0.045;SOR=0.601	GT:AD:DP:GQ:PL	1/0:16,22:280:59:9253,8452,9490
chr5	78968316	78968318	TTA	-	ARSB	intronic	.	.	.	0.520567	1000g2015aug_all	NA	NA	het	280	9236.02	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.2645	0.3582	0.520567	0.0	0.0001921	0.0		0.0					chr5	78968315	.	TTTA	T	9236.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.3;AS_FS=11.606;AS_MQ=59.94;AS_MQRankSum=-0.3;AS_QD=32.72;AS_ReadPosRankSum=0;AS_SOR=0.636;BaseQRankSum=-1.23;DP=367;ExcessHet=3.0103;FS=11.471;MLEAC=1;MLEAF=0.5;MQ=59.96;MQRankSum=-0.231;QD=32.99;ReadPosRankSum=0.045;SOR=0.601	GT:AD:DP:GQ:PL	0/1:16,242:280:59:9253,265,59
chr5	78969218	78969218	A	G	ARSB	intronic	.	.	.	0.4411	GnomAdGenome_AF_ami	31.0	13.0	hom	491	14304.1	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.3237	0.37	0.3722	0.3002	0.4411	0.243011	0.299	0.318101	0.295567	PASS	0.0	0.275	221.0	0.292254	57.0	chr5	78969218	.	A	G	14304.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.13;AS_ReadPosRankSum=.;AS_SOR=0.932;DP=509;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.13;SOR=0.932	GT:AD:DP:GQ:PL	1/1:0,491:491:99:14318,1468,0
chr5	78984774	78984774	C	A	ARSB	intronic	.	.	.	0.2043	GnomAdGenome_AF_asj	17.0	NA	hom	43	931.06	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	not_provided	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1454	0.2043	0.145567	0.0	0.169587	0.186422	PASS	0.0	0.193	30.0			chr5	78984774	.	C	A	931.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=1.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=21.65;AS_ReadPosRankSum=1.1;AS_SOR=0.884;BaseQRankSum=1.76;DP=43;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=21.65;ReadPosRankSum=1.13;SOR=0.884	GT:AD:DP:GQ:PL	1/1:1,42:43:99:945,115,0
chr5	78985550	78985550	T	C	ARSB	UTR5	.	NM_198709:c.-302A>G	.	1.0	GnomAdGenome_AF_ami	149.0	NA	hom	25	675.06	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9444	1.0	0.905152	0.0	0.950515	0.953552	PASS	0.0	0.909	13.0			chr5	78985550	.	T	C	675.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27;AS_ReadPosRankSum=.;AS_SOR=0.77;DP=25;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27;SOR=0.77	GT:AD:DP:GQ:PL	1/1:0,25:25:74:689,74,0
chr5	78985812	78985812	T	C	ARSB	intronic	.	.	.	0.226562	abraom_freq	6.0	NA	hom	22	526.06	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.1666	0.2163	0.171925	0.0	0.0302777	0.226562	PASS	0.0	0.22	55.0			chr5	78985812	.	T	C	526.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=23.91;AS_ReadPosRankSum=.;AS_SOR=0.874;DP=23;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=23.91;SOR=0.874	GT:AD:DP:GQ:PL	1/1:0,22:22:64:540,64,0
chr5	78986086	78986086	-	TG	ARSB	upstream	.	dist=128	.	1.0	GnomAdGenome_AF_ami	128.0	NA	hom	44	1965.03	PASS	.	[MIM:253200]Mucopolysaccharidosis 6 [recessive?];[MIM:272200]Multiple sulfatase deficiency;	611542	.	Mucopolysaccharidosis type 6, slowly progressing;Mucopolysaccharidosis type 6, rapidly progressing	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Toenail selenium levels[25343990;25343990];Iron status biomarkers[19084217];Attention deficit hyperactivity disorder[23728934];Blood and toenail selenium levels[25343990;25343990;25343990;25343990;25343990];Blood protein levels[28240269;28240269;29875488];Hippocampal atrophy[19668339];	HP:0000238;HP:0012185;HP:0001387;HP:0000885;HP:0003311;HP:0001744;HP:0003300;HP:0000365;HP:0002938;HP:0003274;HP:0001385;HP:0000158;HP:0010885;HP:0001638;HP:0002656;HP:0000884;HP:0000023;HP:0007759;HP:0002318;HP:0002788;HP:0003025;HP:0011941;HP:0000256;HP:0000268;HP:0001654;HP:0005280;HP:0000280;HP:0001171;HP:0008301;HP:0000501;HP:0002240;HP:0002857;HP:0002869;HP:0008432;HP:0001007;HP:0002866;HP:0003521;HP:0000007;HP:0001537;HP:0003016;HP:0000943	Hydrocephalus;Constrictive median neuropathy;Joint stiffness;Broad ribs;Hypoplasia of the odontoid process;Splenomegaly;Ovoid vertebral bodies;Hearing impairment;Lumbar hyperlordosis;Hypoplastic acetabulae;Hip dysplasia;Macroglossia;Avascular necrosis;Cardiomyopathy;Epiphyseal dysplasia;Prominent sternum;Inguinal hernia;Opacification of the corneal stroma;Cervical myelopathy;Recurrent upper respiratory tract infections;Metaphyseal irregularity;Anterior wedging of L2;Macrocephaly;Dolichocephaly;Abnormal heart valve morphology;Depressed nasal bridge;Coarse facial features;Split hand;Dermatan sulfate excretion in urine;Glaucoma;Hepatomegaly;Genu valgum;Flared iliac wings;Anterior wedging of L1;Hirsutism;Hypoplastic iliac wing;Disproportionate short-trunk short stature;Autosomal recessive inheritance;Umbilical hernia;Metaphyseal widening;Dysostosis multiplex	Mucopolysaccharidosis_type_6	criteria_provided,_single_submitter	Benign	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	High	Medium	Medium	alveolus;skin;testis;unclassifiable (Anatomical System);kidney;uterus;whole body;pancreas;visual apparatus;cervix;spleen;liver;endometrium;bone;germinal center;brain;heart;bone marrow;lung;ovary;thyroid;lymph node;frontal lobe;colon;placenta;optic nerve;	ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	9.56E-02	N	N	N	N	0.835096712909965	E	Arsb	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9865	1.0	0.951877	0.0	0.0005379	0.979381	PASS	0.0	0.941	17.0			chr5	78986086	.	C	CTG	1965.03	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=31.31;AS_ReadPosRankSum=.;AS_SOR=1.23;DP=44;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=31.72;SOR=1.23	GT:AD:DP:GQ:PL	1/1:0,44:44:99:1979,132,0
chr12	101746745	101746745	A	-	GNPTAB	UTR3	.	NM_024312:c.*419delT	.	0.059441	abraom_freq	NA	NA	het	460	536.6	QD2	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Mucolipidosis,_Type_III_Alpha/Beta	criteria_provided,_single_submitter	Uncertain_significance	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0064	0.0102	0.0	0.0	0.0009989	0.059441	PASS	0.0					chr12	101746744	.	GA	G	536.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=3.502;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.31;AS_ReadPosRankSum=0.4;AS_SOR=0.872;BaseQRankSum=0.531;DP=522;ExcessHet=3.0103;FS=2.868;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=1.31;ReadPosRankSum=0.25;SOR=0.869	GT:AD:DP:GQ:PL	0/1:342,67:460:99:544,0,8954
chr12	101749532	101749532	T	G	GNPTAB	intronic	.	.	.	0.5324	GnomAdGenome_AF_fin	NA	NA	het	519	5266.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4444	0.5324	0.439497	0.0	0.408522	0.0		0.0					chr12	101749532	.	T	G	5266.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.9;AS_FS=1.733;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.15;AS_ReadPosRankSum=0.1;AS_SOR=0.826;BaseQRankSum=0.927;DP=534;ExcessHet=3.0103;FS=1.733;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.15;ReadPosRankSum=0.145;SOR=0.826	GT:AD:DP:GQ:PL	0/1:274,245:519:99:5274,0,5867
chr12	101752020	101752021	AA	-	GNPTAB	intronic	.	.	.	0.0222	GnomAdGenome_AF_fin	NA	NA	het	361	3697.02	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.004	0.0222	0.0	0.0	0.0001153	0.0		0.0					chr12	101752019	.	TAA	T	3697.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.7;AS_FS=1.191;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.09;AS_ReadPosRankSum=0.7;AS_SOR=0.568;BaseQRankSum=0.212;DP=437;ExcessHet=3.0103;FS=4.097;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.28;ReadPosRankSum=-0.242;SOR=0.634	GT:AD:DP:GQ:PL	1/0:87,85:361:99:3714,633,3564
chr12	101752020	101752020	A	-	GNPTAB	intronic	.	.	.	0.6884	GnomAdGenome_AF_afr	NA	NA	het	361	3697.02	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.5824	0.6884	0.61262	0.0	0.0001921	0.0		0.0					chr12	101752019	.	TA	T	3697.02	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.5;AS_FS=3.923;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.88;AS_ReadPosRankSum=-0.7;AS_SOR=0.677;BaseQRankSum=0.212;DP=437;ExcessHet=3.0103;FS=4.097;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.28;ReadPosRankSum=-0.242;SOR=0.634	GT:AD:DP:GQ:PL	0/1:87,129:361:99:3714,198,1616
chr12	101753205	101753205	G	A	GNPTAB	intronic	.	.	.	0.5356	GnomAdGenome_AF_fin	25.0	NA	het	418	3909.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4445	0.5356	0.438898	0.0	0.406793	0.390734	PASS	0.0	0.23	13.0			chr12	101753205	.	G	A	3909.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3.1;AS_FS=2.46;AS_MQ=59.8;AS_MQRankSum=-0.8;AS_QD=9.35;AS_ReadPosRankSum=1.1;AS_SOR=0.583;BaseQRankSum=3.14;DP=437;ExcessHet=3.0103;FS=2.46;MLEAC=1;MLEAF=0.5;MQ=59.89;MQRankSum=-0.745;QD=9.35;ReadPosRankSum=1.11;SOR=0.583	GT:AD:DP:GQ:PL	0/1:235,183:418:99:3917,0,5035
chr12	101753254	101753254	A	-	GNPTAB	intronic	.	.	.	0.04529	abraom_freq	NA	0.0	het	391	794.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.002	0.0065	0.0	0.0	3.84e-05	0.04529	PASS	0.0			0.027778	4.0	chr12	101753253	.	CA	C	794.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.9;AS_FS=2.327;AS_MQ=59.96;AS_MQRankSum=-2;AS_QD=2.43;AS_ReadPosRankSum=0.8;AS_SOR=0.836;BaseQRankSum=0.694;DP=465;ExcessHet=3.0103;FS=1.749;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=-2.462;QD=2.43;ReadPosRankSum=0.618;SOR=0.758	GT:AD:DP:GQ:PL	0/1:260,67:391:99:802,0,6851
chr12	101753376	101753376	C	T	GNPTAB	exonic	nonsynonymous SNV	.	GNPTAB:NM_024312:exon19:c.G3598A:p.E1200K	0.026515	GME_CA	0.0	0.0	het	519	5249.64	PASS	24.2	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	D	D	P	B	D	D	L	D	D	T	T	T	.	D	T	T	T	D	.;	D	D	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0031	0.0214	0.0213	0.0008	0.0157	0.00499201	0.0005	0.0030724	0.0		0.026515	0.013	21.0	0.03169	9.0	chr12	101753376	.	C	T	5249.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.12;AS_ReadPosRankSum=0;AS_SOR=0.704;BaseQRankSum=1.24;DP=531;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.11;ReadPosRankSum=0.035;SOR=0.704	GT:AD:DP:GQ:PL	0/1:285,234:519:99:5257,0,6688
chr12	101757100	101757100	G	C	GNPTAB	intronic	.	.	.	0.9076	GnomAdGenome_AF_eas	100.0	62.0	het	470	5350.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6106	0.9076	0.690495	0.0	0.110814	0.591133	PASS	0.0	0.648	107.0	0.643885	55.0	chr12	101757100	.	G	C	5350.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.8;AS_FS=1.756;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.39;AS_ReadPosRankSum=1.2;AS_SOR=0.852;BaseQRankSum=1.81;DP=479;ExcessHet=3.0103;FS=1.756;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.38;ReadPosRankSum=1.28;SOR=0.852	GT:AD:DP:GQ:PL	0/1:241,229:470:99:5358,0,5510
chr12	101757335	101757335	A	G	GNPTAB	intronic	.	.	.	0.4436	GnomAdGenome_AF_fin	12.0	7.0	het	731	7853.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.3202	0.3952	0.3963	0.3082	0.4436	0.307508	0.293	0.30107	0.273399	PASS	0.0	0.186	167.0	0.187943	39.0	chr12	101757335	.	A	G	7853.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.2;AS_FS=1.731;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.74;AS_ReadPosRankSum=0.7;AS_SOR=0.651;BaseQRankSum=-0.2;DP=749;ExcessHet=3.0103;FS=1.731;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.74;ReadPosRankSum=0.718;SOR=0.651	GT:AD:DP:GQ:PL	0/1:385,346:731:99:7861,0,9036
chr12	101757960	101757960	G	C	GNPTAB	intronic	.	.	.	0.4458	GnomAdGenome_AF_fin	2.0	NA	het	485	5555.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.3081	0.4458	0.307508	0.0	0.304672	0.292373	PASS	0.0	0.043	4.0			chr12	101757960	.	G	C	5555.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.7;AS_FS=1.124;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.46;AS_ReadPosRankSum=0.2;AS_SOR=0.839;BaseQRankSum=1.79;DP=504;ExcessHet=3.0103;FS=1.124;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.45;ReadPosRankSum=0.27;SOR=0.839	GT:AD:DP:GQ:PL	0/1:250,235:485:99:5563,0,5934
chr12	101758038	101758038	T	-	GNPTAB	intronic	.	.	.	0.4808	GnomAdGenome_AF_afr	NA	NA	het	253	1014.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2877	0.4808	0.317692	0.0	0.0004995	0.0		0.0					chr12	101758037	.	AT	A	1014.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.7;AS_FS=9.007;AS_MQ=59.59;AS_MQRankSum=-0.7;AS_QD=3.17;AS_ReadPosRankSum=0.4;AS_SOR=0.918;BaseQRankSum=-0.824;DP=420;ExcessHet=3.0103;FS=4.485;MLEAC=1;MLEAF=0.5;MQ=59.28;MQRankSum=-1.67;QD=6.04;ReadPosRankSum=0.522;SOR=0.633	GT:AD:DP:GQ:PL	0/1:88,80:253:99:1022,0,2432
chr12	101758447	101758447	C	T	GNPTAB	intronic	.	.	.	0.9067	GnomAdGenome_AF_eas	NA	NA	het	659	7844.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6173	0.9067	0.696086	0.0	0.0001537	0.0		0.0					chr12	101758447	.	C	T	7844.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=1;AS_QD=11.9;AS_ReadPosRankSum=-0.4;AS_SOR=0.734;BaseQRankSum=-0.182;DP=684;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.99;MQRankSum=1.03;QD=11.9;ReadPosRankSum=-0.322;SOR=0.734	GT:AD:DP:GQ:PL	0/1:322,337:659:99:7852,0,7483
chr12	101759102	101759102	G	T	GNPTAB	intronic	.	.	.	0.9075	GnomAdGenome_AF_eas	NA	NA	het	616	6383.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.5814	0.9075	0.650759	0.0	0.564162	0.0		0.0					chr12	101759102	.	G	T	6383.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=4.6;AS_FS=1.1;AS_MQ=59.96;AS_MQRankSum=0.9;AS_QD=10.36;AS_ReadPosRankSum=-0.7;AS_SOR=0.639;BaseQRankSum=4.64;DP=641;ExcessHet=3.0103;FS=1.1;MLEAC=1;MLEAF=0.5;MQ=59.92;MQRankSum=0.938;QD=10.36;ReadPosRankSum=-0.664;SOR=0.639	GT:AD:DP:GQ:PL	0/1:318,298:616:99:6391,0,5926
chr12	101759224	101759224	G	A	GNPTAB	intronic	.	.	.	0.4446	GnomAdGenome_AF_fin	NA	NA	het	454	5092.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.3075	0.4446	0.307907	0.0	0.0364226	0.0		0.0					chr12	101759224	.	G	A	5092.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=4.6;AS_FS=1.093;AS_MQ=56.45;AS_MQRankSum=-1.8;AS_QD=11.22;AS_ReadPosRankSum=-0.3;AS_SOR=0.79;BaseQRankSum=4.66;DP=462;ExcessHet=3.0103;FS=1.093;MLEAC=1;MLEAF=0.5;MQ=56.79;MQRankSum=-1.746;QD=11.22;ReadPosRankSum=-0.206;SOR=0.79	GT:AD:DP:GQ:PL	0/1:230,224:454:99:5100,0,4863
chr12	101759363	101759363	A	-	GNPTAB	intronic	.	.	.	0.0903	GnomAdGenome_AF_afr	NA	NA	het	120	221.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0264	0.0903	0.0	0.0	1.94e-05	0.0		0.0					chr12	101759362	.	CA	C	221.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.4;AS_FS=1.05;AS_MQ=58.68;AS_MQRankSum=0.8;AS_QD=2.15;AS_ReadPosRankSum=1.3;AS_SOR=0.5;BaseQRankSum=0.939;DP=224;ExcessHet=3.0103;FS=0.831;MLEAC=1;MLEAF=0.5;MQ=59.37;MQRankSum=1.21;QD=2.74;ReadPosRankSum=1.77;SOR=0.592	GT:AD:DP:GQ:PL	0/1:58,23:120:99:229,0,1162
chr12	101759420	101759420	A	-	GNPTAB	intronic	.	.	.	0.0223	GnomAdGenome_AF_afr	NA	NA	het	310	1409.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0131	0.0223	0.0	0.0	9.06e-05	0.0		0.0					chr12	101759419	.	TA	T	1409.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.59;AS_ReadPosRankSum=-1.3;AS_SOR=0.702;BaseQRankSum=-0.024;DP=341;ExcessHet=3.0103;FS=2.013;MLEAC=1;MLEAF=0.5;MQ=59.93;MQRankSum=0;QD=5.78;ReadPosRankSum=-1.174;SOR=0.578	GT:AD:DP:GQ:PL	0/1:163,81:310:99:1417,0,3834
chr12	101760438	101760438	C	T	GNPTAB	intronic	.	.	.	0.1149	GnomAdGenome_AF_fin	NA	NA	het	799	9770.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0638	0.1149	0.0523163	0.0	0.0122443	0.059659	PASS	0.0					chr12	101760438	.	C	T	9770.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2;AS_FS=1.1;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.23;AS_ReadPosRankSum=1.9;AS_SOR=0.752;BaseQRankSum=2.07;DP=826;ExcessHet=3.0103;FS=1.1;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.23;ReadPosRankSum=1.92;SOR=0.752	GT:AD:DP:GQ:PL	0/1:389,410:799:99:9778,0,8793
chr12	101760782	101760782	T	-	GNPTAB	intronic	.	.	.	0.0074	GnomAdGenome_AF_fin	NA	NA	het	421	1566.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0014	0.0074	0.0	0.0	0.0001537	0.0		0.0					chr12	101760781	.	CT	C	1566.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.1;AS_FS=0.956;AS_MQ=60;AS_MQRankSum=1.2;AS_QD=2.16;AS_ReadPosRankSum=-0.6;AS_SOR=0.769;BaseQRankSum=0.678;DP=553;ExcessHet=3.0103;FS=1.757;MLEAC=1;MLEAF=0.5;MQ=59.83;MQRankSum=0.931;QD=5.1;ReadPosRankSum=-0.734;SOR=0.797	GT:AD:DP:GQ:PL	0/1:194,113:421:99:1574,0,4117
chr12	101761122	101761122	A	G	GNPTAB	intronic	.	.	.	0.9072	GnomAdGenome_AF_eas	325.0	63.0	het	926	8506.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.0001	0.02	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.5992	0.9053	0.9051	0.6106	0.9072	0.690495	0.5967	0.58637	0.596059	PASS	0.0	0.65	339.0	0.669014	64.0	chr12	101761122	.	A	G	8506.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-9.5;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=9.19;AS_ReadPosRankSum=-1.3;AS_SOR=0.672;BaseQRankSum=-9.428;DP=950;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=9.19;ReadPosRankSum=-1.216;SOR=0.672	GT:AD:DP:GQ:PL	0/1:446,480:926:99:8514,0,10206
chr12	101762525	101762525	A	T	GNPTAB	intronic	.	.	.	0.9073	GnomAdGenome_AF_eas	NA	NA	het	788	9048.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6095	0.9073	0.689696	0.0	0.0001153	0.0		0.0					chr12	101762525	.	A	T	9048.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-5;AS_FS=0.521;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.48;AS_ReadPosRankSum=1.2;AS_SOR=0.735;BaseQRankSum=-4.996;DP=818;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.48;ReadPosRankSum=1.27;SOR=0.735	GT:AD:DP:GQ:PL	0/1:381,407:788:99:9056,0,8912
chr12	101762904	101762904	A	-	GNPTAB	intronic	.	.	.	0.3193	GnomAdGenome_AF_eas	NA	NA	het	294	1084.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0249	0.3193	0.0	0.0	0.0001537	0.0		0.0					chr12	101762903	.	TA	T	1084.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=0.628;AS_MQ=58.1;AS_MQRankSum=-0.1;AS_QD=0.82;AS_ReadPosRankSum=0.7;AS_SOR=0.799;BaseQRankSum=-0.216;DP=496;ExcessHet=3.0103;FS=0.53;MLEAC=1;MLEAF=0.5;MQ=59.51;MQRankSum=-0.683;QD=5.48;ReadPosRankSum=-0.161;SOR=0.621	GT:AD:DP:GQ:PL	0/1:126,72:294:99:1092,0,1851
chr12	101763236	101763238	AAG	-	GNPTAB	intronic	.	.	.	0.0018	GnomAdGenome_AF_eas	NA	NA	het	397	178.6	QD2	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0003	0.0018	0.0	0.0	0.0001153	0.0		0.0					chr12	101763235	.	AAAG	A	178.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.8;AS_FS=3.176;AS_MQ=55.94;AS_MQRankSum=-0.8;AS_QD=0.45;AS_ReadPosRankSum=-0.3;AS_SOR=0.621;BaseQRankSum=-0.782;DP=477;ExcessHet=3.0103;FS=3.176;MLEAC=1;MLEAF=0.5;MQ=59.75;MQRankSum=-0.726;QD=0.45;ReadPosRankSum=-0.258;SOR=0.621	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:329,68:397:99:0|1:101763235_AAAG_A:186,0,10581:101763235
chr12	101763451	101763451	T	-	GNPTAB	intronic	.	.	.	0.003	GnomAdGenome_AF_afr	NA	NA	het	586	1531.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0012	0.003	0.0	0.0	8.41e-05	0.0		0.0					chr12	101763450	.	AT	A	1531.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.85;AS_ReadPosRankSum=-0.7;AS_SOR=0.665;BaseQRankSum=-0.564;DP=663;ExcessHet=3.0103;FS=1.244;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.85;ReadPosRankSum=-1.121;SOR=0.791	GT:AD:DP:GQ:PL	0/1:424,114:586:99:1539,0,10652
chr12	101763775	101763775	G	C	GNPTAB	intronic	.	.	.	0.4004	GnomAdGenome_AF_fin	NA	NA	het	784	8647.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2602	0.4004	0.244609	0.0	0.280198	0.0		0.0					chr12	101763775	.	G	C	8647.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.1;AS_FS=1.101;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.03;AS_ReadPosRankSum=-1.4;AS_SOR=0.79;BaseQRankSum=0.112;DP=815;ExcessHet=3.0103;FS=1.101;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.03;ReadPosRankSum=-1.397;SOR=0.79	GT:AD:DP:GQ:PL	0/1:397,387:784:99:8655,0,8927
chr12	101764985	101764985	T	C	GNPTAB	exonic	synonymous SNV	.	GNPTAB:NM_024312:exon13:c.A1932G:p.T644T	0.9067	GnomAdGenome_AF_eas	347.0	63.0	het	671	7405.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	Benign	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.5903	0.9046	0.9045	0.581	0.9067	0.651358	0.5625	0.0033053	0.565681	PASS	0.655172	0.641	376.0	0.669014	64.0	chr12	101764985	.	T	C	7405.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.4;AS_FS=2.444;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.04;AS_ReadPosRankSum=0.7;AS_SOR=0.788;BaseQRankSum=-2.321;DP=707;ExcessHet=3.0103;FS=2.444;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.04;ReadPosRankSum=0.753;SOR=0.788	GT:AD:DP:GQ:PL	0/1:329,342:671:99:7413,0,7519
chr12	101767325	101767325	A	G	GNPTAB	intronic	.	.	.	0.5719	GnomAdGenome_AF_afr	NA	NA	het	659	7542.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4606	0.5719	0.465855	0.0	0.0697404	0.0		0.0					chr12	101767325	.	A	G	7542.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.3;AS_FS=1.14;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.45;AS_ReadPosRankSum=-0.6;AS_SOR=0.786;BaseQRankSum=-0.201;DP=681;ExcessHet=3.0103;FS=1.14;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.45;ReadPosRankSum=-0.52;SOR=0.786	GT:AD:DP:GQ:PL	0/1:327,332:659:99:7550,0,7328
chr12	101768326	101768326	C	T	GNPTAB	intronic	.	.	.	0.9056	GnomAdGenome_AF_eas	84.0	NA	het	655	7228.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.5812	0.9056	0.64996	0.0	0.564623	0.565506	PASS	0.0	0.601	40.0			chr12	101768326	.	C	T	7228.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=1.722;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.04;AS_ReadPosRankSum=0.3;AS_SOR=0.822;BaseQRankSum=0.394;DP=672;ExcessHet=3.0103;FS=1.722;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.04;ReadPosRankSum=0.323;SOR=0.822	GT:AD:DP:GQ:PL	0/1:331,324:655:99:7236,0,7478
chr12	101768547	101768547	G	A	GNPTAB	intronic	.	.	.	0.5326	GnomAdGenome_AF_fin	NA	NA	het	643	6920.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.4441	0.5326	0.439696	0.0	0.0686537	0.0		0.0					chr12	101768547	.	G	A	6920.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.6;AS_FS=3.189;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.76;AS_ReadPosRankSum=-1.1;AS_SOR=0.897;BaseQRankSum=-1.544;DP=661;ExcessHet=3.0103;FS=3.189;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.76;ReadPosRankSum=-1.027;SOR=0.897	GT:AD:DP:GQ:PL	0/1:332,311:643:99:6928,0,7658
chr12	101769256	101769256	T	C	GNPTAB	intronic	.	.	.	0.907	GnomAdGenome_AF_eas	NA	NA	het	557	6372.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6098	0.907	0.689696	0.0	0.575995	0.0		0.0					chr12	101769256	.	T	C	6372.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.5;AS_FS=1.09;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.48;AS_ReadPosRankSum=-0.1;AS_SOR=0.616;BaseQRankSum=0.436;DP=575;ExcessHet=3.0103;FS=0.521;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.48;ReadPosRankSum=-0.08;SOR=0.616	GT:AD:DP:GQ:PL	0/1:272,283:557:99:6380,0,6088
chr12	101769315	101769315	G	C	GNPTAB	intronic	.	.	.	2.389e-05	GnomAdGenome_AF_afr	NA	NA	het	553	6260.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	6.997e-06	2.389e-05	0.0	0.0	0.0	0.0		0.0					chr12	101769315	.	G	C	6260.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.2;AS_FS=1.741;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.32;AS_ReadPosRankSum=-0.8;AS_SOR=0.76;BaseQRankSum=-1.125;DP=570;ExcessHet=3.0103;FS=1.741;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.32;ReadPosRankSum=-0.784;SOR=0.76	GT:AD:DP:GQ:PL	0/1:263,290:553:99:6268,0,5695
chr12	101771247	101771247	T	-	GNPTAB	intronic	.	.	.	0.295983	abraom_freq	3.0	1.0	het	268	755.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Likely_benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0143	0.0399	0.0	0.0	0.0001921	0.295983	PASS	0.0	0.065	11.0	0.127907	31.0	chr12	101771246	.	CT	C	755.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.4;AS_FS=5.032;AS_MQ=60;AS_MQRankSum=0;AS_QD=1.35;AS_ReadPosRankSum=2.1;AS_SOR=0.74;BaseQRankSum=2.3;DP=386;ExcessHet=3.0103;FS=3.526;MLEAC=1;MLEAF=0.5;MQ=59.9;MQRankSum=0;QD=4.87;ReadPosRankSum=2.06;SOR=0.516	GT:AD:DP:GQ:PL	0/1:100,55:268:99:763,0,2905
chr12	101771305	101771305	A	G	GNPTAB	intronic	.	.	.	0.9064	GnomAdGenome_AF_eas	44.0	31.0	het	373	3846.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6133	0.9064	0.69389	0.0	0.0001921	0.605263	PASS	0.0	0.465	18.0	0.570312	11.0	chr12	101771305	.	A	G	3846.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.7;AS_FS=0.377;AS_MQ=59.96;AS_MQRankSum=0.1;AS_QD=10.31;AS_ReadPosRankSum=2.8;AS_SOR=0.737;BaseQRankSum=-2.659;DP=388;ExcessHet=3.0103;FS=0.377;MLEAC=1;MLEAF=0.5;MQ=59.91;MQRankSum=0.122;QD=10.31;ReadPosRankSum=2.82;SOR=0.737	GT:AD:DP:GQ:PL	0/1:171,202:373:99:3854,0,3336
chr12	101771564	101771564	G	A	GNPTAB	intronic	.	.	.	0.3999	GnomAdGenome_AF_fin	NA	NA	het	693	7667.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.2429	0.3999	0.223842	0.0	0.274358	0.0		0.0					chr12	101771564	.	G	A	7667.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.6;AS_FS=0;AS_MQ=60;AS_MQRankSum=0.9;AS_QD=11.06;AS_ReadPosRankSum=-0.1;AS_SOR=0.7;BaseQRankSum=-0.592;DP=731;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0.999;QD=11.06;ReadPosRankSum=-0.062;SOR=0.7	GT:AD:DP:GQ:PL	0/1:348,345:693:99:7675,0,7937
chr12	101778905	101778905	A	-	GNPTAB	intronic	.	.	.	0.0016	GnomAdGenome_AF_fin	NA	NA	het	302	979.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0004	0.0016	0.0	0.0	0.0002305	0.0		0.0					chr12	101778904	.	CA	C	979.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.2;AS_FS=1.727;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.59;AS_ReadPosRankSum=0.6;AS_SOR=0.793;BaseQRankSum=0.909;DP=347;ExcessHet=3.0103;FS=2.067;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0;QD=3.59;ReadPosRankSum=0.864;SOR=0.776	GT:AD:DP:GQ:PL	0/1:207,66:302:99:987,0,5157
chr12	101778917	101778917	C	T	GNPTAB	intronic	.	.	.	0.9115	GnomAdGenome_AF_eas	NA	NA	het	338	1649.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6346	0.9115	0.718251	0.0	0.0003074	0.0		0.0					chr12	101778917	.	C	T	1649.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.1;AS_FS=1.427;AS_MQ=60;AS_MQRankSum=0;AS_QD=4.88;AS_ReadPosRankSum=1.6;AS_SOR=0.61;BaseQRankSum=-1.02;DP=350;ExcessHet=3.0103;FS=1.427;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0;QD=4.88;ReadPosRankSum=1.64;SOR=0.61	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:241,97:338:99:0|1:101778905_A_*:1657,0,5926:101778905
chr12	101779034	101779035	GA	-	GNPTAB	intronic	.	.	.	0.3138	GnomAdGenome_AF_eas	NA	NA	het	384	2212.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0165	0.3138	0.0	0.0	0.00073	0.0		0.0					chr12	101779033	.	GGA	G	2212.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=2.855;AS_MQ=60;AS_MQRankSum=0;AS_QD=5.76;AS_ReadPosRankSum=-0.8;AS_SOR=0.904;BaseQRankSum=0.663;DP=399;ExcessHet=3.0103;FS=2.855;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.76;ReadPosRankSum=-0.787;SOR=0.904	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:309,75:384:99:0|1:101779033_GGA_G:2220,0,12718:101779033
chr12	101779037	101779037	A	T	GNPTAB	intronic	.	.	.	0.3144	GnomAdGenome_AF_eas	NA	NA	het	387	2202.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0166	0.3144	0.0900559	0.0	0.0174812	0.0		0.0					chr12	101779037	.	A	T	2202.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.3;AS_FS=3.554;AS_MQ=60;AS_MQRankSum=0;AS_QD=5.69;AS_ReadPosRankSum=-0.6;AS_SOR=0.914;BaseQRankSum=0.378;DP=389;ExcessHet=3.0103;FS=3.554;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.69;ReadPosRankSum=-0.59;SOR=0.914	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:312,75:387:99:0|1:101779033_GGA_G:2210,0,12844:101779033
chr12	101779039	101779039	A	T	GNPTAB	intronic	.	.	.	0.3139	GnomAdGenome_AF_eas	NA	NA	het	384	2211.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0166	0.3139	0.0900559	0.0	0.0174812	0.0		0.0					chr12	101779039	.	A	T	2211.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.2;AS_FS=4.326;AS_MQ=60;AS_MQRankSum=0;AS_QD=5.76;AS_ReadPosRankSum=-0.6;AS_SOR=0.951;BaseQRankSum=2.2;DP=386;ExcessHet=3.0103;FS=4.326;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.76;ReadPosRankSum=-0.517;SOR=0.951	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:309,75:384:99:0|1:101779033_GGA_G:2219,0,12749:101779033
chr12	101779042	101779044	AGT	-	GNPTAB	intronic	.	.	.	0.3149	GnomAdGenome_AF_eas	NA	NA	het	394	2316.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0166	0.3149	0.0	0.0	0.0010758	0.0		0.0					chr12	101779041	.	AAGT	A	2316.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=5.061;AS_MQ=60;AS_MQRankSum=0;AS_QD=5.88;AS_ReadPosRankSum=-0.9;AS_SOR=0.994;BaseQRankSum=1.08;DP=396;ExcessHet=3.0103;FS=5.061;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=5.88;ReadPosRankSum=-0.839;SOR=0.994	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:316,78:394:99:0|1:101779033_GGA_G:2324,0,13034:101779033
chr12	101779050	101779050	G	-	GNPTAB	intronic	.	.	.	0.316	GnomAdGenome_AF_eas	NA	NA	het	387	2382.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0167	0.316	0.0	0.0	0.00073	0.0		0.0					chr12	101779049	.	AG	A	2382.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=5.029;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.16;AS_ReadPosRankSum=-1.2;AS_SOR=0.986;BaseQRankSum=0.651;DP=388;ExcessHet=3.0103;FS=5.029;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.16;ReadPosRankSum=-1.153;SOR=0.986	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:308,79:387:99:0|1:101779033_GGA_G:2390,0,12695:101779033
chr12	101779051	101779051	G	C	GNPTAB	intronic	.	.	.	0.3162	GnomAdGenome_AF_eas	NA	NA	het	389	2376.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0167	0.3162	0.0	0.0	0.0001537	0.0		0.0					chr12	101779051	.	G	C	2376.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.1;AS_FS=3.474;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.11;AS_ReadPosRankSum=-1;AS_SOR=0.924;BaseQRankSum=-0.001;DP=390;ExcessHet=3.0103;FS=3.474;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.11;ReadPosRankSum=-0.986;SOR=0.924	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:310,79:389:99:0|1:101779033_GGA_G:2384,0,12779:101779033
chr12	101779053	101779053	A	C	GNPTAB	intronic	.	.	.	0.3163	GnomAdGenome_AF_eas	NA	NA	het	388	2379.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0167	0.3163	0.0900559	0.0	0.0174812	0.0		0.0					chr12	101779053	.	A	C	2379.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.6;AS_FS=4.215;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.13;AS_ReadPosRankSum=-1.1;AS_SOR=0.947;BaseQRankSum=0.678;DP=389;ExcessHet=3.0103;FS=4.215;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.13;ReadPosRankSum=-1.08;SOR=0.947	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:309,79:388:99:0|1:101779033_GGA_G:2387,0,12723:101779033
chr12	101779060	101779060	-	G	GNPTAB	intronic	.	.	.	0.3188	GnomAdGenome_AF_eas	NA	NA	het	389	2540.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.017	0.3188	0.0908546	0.0	0.0001921	0.0		0.0					chr12	101779060	.	T	TG	2540.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.7;AS_FS=9.627;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.57;AS_ReadPosRankSum=-0.3;AS_SOR=1.19;BaseQRankSum=1.52;DP=401;ExcessHet=3.0103;FS=9.49;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=6.56;ReadPosRankSum=-0.046;SOR=1.174	GT:AD:DP:GQ:PL	0/1:302,85:389:99:2548,0,12526
chr12	101779074	101779074	A	-	GNPTAB	intronic	.	.	.	0.3211	GnomAdGenome_AF_eas	NA	NA	het	372	1184.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0173	0.3211	0.0960463	0.0	0.0056862	0.0		0.0					chr12	101779073	.	TA	T	1184.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.1;AS_FS=3.672;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.19;AS_ReadPosRankSum=1;AS_SOR=0.925;BaseQRankSum=0.136;DP=381;ExcessHet=3.0103;FS=3.672;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.18;ReadPosRankSum=1.07;SOR=0.925	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:302,70:372:99:0|1:101779033_GGA_G:1192,0,12102:101779033
chr12	101779876	101779876	T	C	GNPTAB	intronic	.	.	.	0.9237	GnomAdGenome_AF_eas	NA	NA	het	368	1163.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6405	0.9237	0.727436	0.0	0.0994748	0.627796	PASS	0.0					chr12	101779876	.	T	C	1163.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.2;AS_FS=2.057;AS_MQ=60;AS_MQRankSum=0;AS_QD=3.16;AS_ReadPosRankSum=-0.3;AS_SOR=0.839;BaseQRankSum=-1.104;DP=377;ExcessHet=3.0103;FS=2.057;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=3.16;ReadPosRankSum=-0.275;SOR=0.839	GT:AD:DP:GQ:PL	0/1:282,86:368:99:1171,0,6770
chr12	101786450	101786450	C	T	GNPTAB	intronic	.	.	.	0.9241	GnomAdGenome_AF_eas	58.0	NA	het	650	6702.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6728	0.9241	0.749002	0.0	0.0001153	0.624542	PASS	0.0	0.539	21.0			chr12	101786450	.	C	T	6702.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2;AS_FS=1.75;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.31;AS_ReadPosRankSum=-1.5;AS_SOR=0.837;BaseQRankSum=2.01;DP=672;ExcessHet=3.0103;FS=1.75;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.31;ReadPosRankSum=-1.496;SOR=0.837	GT:AD:DP:GQ:PL	0/1:352,298:650:99:6710,0,8184
chr12	101787577	101787577	A	G	GNPTAB	intronic	.	.	.	0.4917	GnomAdGenome_AF_eas	NA	NA	het	494	5918.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.1297	0.4917	0.213059	0.0	0.0001153	0.0		0.0					chr12	101787577	.	A	G	5918.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1;AS_FS=2.452;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.98;AS_ReadPosRankSum=-1.1;AS_SOR=0.899;BaseQRankSum=-0.972;DP=510;ExcessHet=3.0103;FS=2.452;MLEAC=1;MLEAF=0.5;MQ=59.97;MQRankSum=0;QD=11.98;ReadPosRankSum=-1.023;SOR=0.899	GT:AD:DP:GQ:PL	0/1:243,251:494:99:5926,0,5639
chr12	101787913	101787913	-	A	GNPTAB	intronic	.	.	.	0.8168	GnomAdGenome_AF_amr	NA	NA	het	163	1261.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.7061	0.8168	0.701877	0.0	0.0004226	0.0		0.0					chr12	101787913	.	C	CA	1261.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-2.1;AS_FS=6.519;AS_MQ=59.78;AS_MQRankSum=0.2;AS_QD=1.79;AS_ReadPosRankSum=0;AS_SOR=1.46;BaseQRankSum=-2.044;DP=311;ExcessHet=3.0103;FS=0;MLEAC=1;MLEAF=0.5;MQ=58.39;MQRankSum=-1.439;QD=14.67;ReadPosRankSum=-0.351;SOR=0.754	GT:AD:DP:GQ:PL	0/1:37,49:163:99:1269,0,673
chr12	101788403	101788403	G	A	GNPTAB	intronic	.	.	.	0.9236	GnomAdGenome_AF_eas	66.0	65.0	het	608	6790.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6025	0.9236	0.684305	0.0	0.106693	0.57743	PASS	0.0	0.53	44.0	0.656028	55.0	chr12	101788403	.	G	A	6790.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.2;AS_FS=4.012;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.17;AS_ReadPosRankSum=-0.3;AS_SOR=0.922;BaseQRankSum=2.24;DP=626;ExcessHet=3.0103;FS=4.012;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.17;ReadPosRankSum=-0.203;SOR=0.922	GT:AD:DP:GQ:PL	0/1:309,299:608:99:6798,0,6809
chr12	101788791	101788791	A	G	GNPTAB	intronic	.	.	.	0.322	GnomAdGenome_AF_eas	12.0	NA	het	617	7517.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Likely_benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0175	0.322	0.0976438	0.0	0.035116	0.013136	PASS	0.0	0.156	28.0			chr12	101788791	.	A	G	7517.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-6.2;AS_FS=0.524;AS_MQ=60;AS_MQRankSum=0;AS_QD=12.18;AS_ReadPosRankSum=-1.3;AS_SOR=0.611;BaseQRankSum=-6.163;DP=638;ExcessHet=3.0103;FS=0.524;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=12.18;ReadPosRankSum=-1.206;SOR=0.611	GT:AD:DP:GQ:PL	0/1:267,350:617:99:7525,0,6126
chr12	101788929	101788929	A	T	GNPTAB	intronic	.	.	.	0.9236	GnomAdGenome_AF_eas	NA	NA	het	659	7113.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.6205	0.9236	0.707468	0.0	0.0960078	0.0		0.0					chr12	101788929	.	A	T	7113.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.9;AS_FS=1.742;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.8;AS_ReadPosRankSum=0.3;AS_SOR=0.797;BaseQRankSum=-0.849;DP=672;ExcessHet=3.0103;FS=1.742;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.79;ReadPosRankSum=0.367;SOR=0.797	GT:AD:DP:GQ:PL	0/1:338,321:659:99:7121,0,7779
chr12	101789465	101789466	TA	-	GNPTAB	intronic	.	.	.	0.3203	GnomAdGenome_AF_eas	NA	NA	het	664	12328.6	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0174	0.3203	0.0976438	0.0	0.001022	0.0		0.0					chr12	101789464	.	CTA	C	12328.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=0.4;AS_FS=3.192;AS_MQ=60;AS_MQRankSum=0;AS_QD=18.57;AS_ReadPosRankSum=0;AS_SOR=0.541;BaseQRankSum=0.413;DP=693;ExcessHet=3.0103;FS=3.192;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=18.57;ReadPosRankSum=0.073;SOR=0.541	GT:AD:DP:GQ:PL	0/1:341,323:664:99:12336,0,13191
chr12	101790072	101790072	C	A	GNPTAB	intronic	.	.	.	0.3247	GnomAdExome_AF_eas	29.0	5.0	het	671	7931.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0478	0.3247	0.3223	0.0175	0.321	0.0976438	0.0038	0.0439774	0.013136	PASS	0.0	0.167	218.0	0.172535	39.0	chr12	101790072	.	C	A	7931.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3.4;AS_FS=1.109;AS_MQ=60;AS_MQRankSum=0;AS_QD=11.82;AS_ReadPosRankSum=-0.7;AS_SOR=0.8;BaseQRankSum=3.45;DP=702;ExcessHet=3.0103;FS=1.109;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=11.82;ReadPosRankSum=-0.647;SOR=0.8	GT:AD:DP:GQ:PL	0/1:327,344:671:99:7939,0,7143
chr12	101790160	101790160	C	A	GNPTAB	intronic	.	.	.	0.4901	GnomAdGenome_AF_eas	14.0	8.0	het	662	7243.64	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	Mucolipidosis_type_II|Pseudo-Hurler_polydystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.1263	0.4901	0.211462	0.0	0.0253684	0.158456	PASS	0.0	0.26	81.0	0.253521	56.0	chr12	101790160	.	C	A	7243.64	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-1.8;AS_FS=1.753;AS_MQ=60;AS_MQRankSum=0;AS_QD=10.94;AS_ReadPosRankSum=-0.1;AS_SOR=0.821;BaseQRankSum=-1.756;DP=708;ExcessHet=3.0103;FS=1.753;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=10.94;ReadPosRankSum=-0.057;SOR=0.821	GT:AD:DP:GQ:PL	0/1:347,315:662:99:7251,0,8368
chr12	101790293	101790293	C	T	GNPTAB	intronic	.	.	.	0.9994	GnomAdGenome_AF_eas	113.0	NA	hom	602	17585.1	PASS	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	not_provided	criteria_provided,_single_submitter	Benign	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.9716	0.9994	0.982428	0.0	0.161395	0.978261	PASS	0.0	0.942	2.0			chr12	101790293	.	C	T	17585.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.31;AS_ReadPosRankSum=.;AS_SOR=0.866;DP=610;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.31;SOR=0.873	GT:AD:DP:GQ:PL	1/1:0,600:602:99:17599,1798,0
chr12	101796904	101796904	A	G	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	533	1447.64	FS60;SOR3	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101796904	.	A	G	1447.64	FS60;SOR3	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=6.3;AS_FS=220.161;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.72;AS_ReadPosRankSum=-5.6;AS_SOR=11.226;BaseQRankSum=6.3;DP=540;ExcessHet=3.0103;FS=220.161;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.72;ReadPosRankSum=-5.584;SOR=11.226	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:260,273:533:99:0|1:101796904_A_G:1455,0,5797:101796904
chr12	101796910	101796910	-	GACTGGCCGTC	GNPTAB	intronic	.	.	.	0.0	GnomAdExome_AF	NA	NA	het	525	1471.6	FS200	.	[MIM:252500]Mucolipidosis type II [recessive?];[MIM:252600]Mucolipidosis type III complementation group A;	607840	.	Mucolipidosis type II;Mucolipidosis type III alpha/beta	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Bone mineral density (total hip)[29883787];Blood protein levels[28240269;28240269;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488;29875488];	HP:0008470;HP:0008850;HP:0000938;HP:0001639;HP:0000403;HP:0100540;HP:0002690;HP:0006610;HP:0009092;HP:0000341;HP:0000343;HP:0003333;HP:0001762;HP:0002869;HP:0003300;HP:0001538;HP:0003026;HP:0030148;HP:0001547;HP:0011344;HP:0001609;HP:0002684;HP:0007759;HP:0003423;HP:0001171;HP:0003264;HP:0000485;HP:0001640;HP:0001635;HP:0001537;HP:0000286;HP:0000882;HP:0001263;HP:0000158;HP:0000463;HP:0001498;HP:0002827;HP:0002196;HP:0004562;HP:0000007;HP:0008155;HP:0009769;HP:0001540;HP:0002837;HP:0002240;HP:0003538;HP:0005280;HP:0001508;HP:0001319;HP:0000535;HP:0000348;HP:0000280;HP:0003414;HP:0001744;HP:0003016;HP:0003180;HP:0002756;HP:0003819;HP:0003311;HP:0000023;HP:0006362;HP:0001048;HP:0006532;HP:0001659;HP:0001328;HP:0002650;HP:0001171;HP:0003026;HP:0000484;HP:0001498;HP:0000773;HP:0012185;HP:0007759;HP:0004236;HP:0003333;HP:0000488;HP:0000546;HP:0000303;HP:0001659;HP:0002680;HP:0001249;HP:0000280;HP:0001363;HP:0003264;HP:0006162;HP:0003182;HP:0000943;HP:0001072;HP:0000007;HP:0000885;HP:0004322;HP:0003538;HP:0001540;HP:0006248;HP:0002870;HP:0000774;HP:0006203;HP:0002827;HP:0000586;HP:0001562;HP:0003273;HP:0100543;HP:0001072;HP:0011471;HP:0045027;HP:0000407;HP:0001824;HP:0006596;HP:0008897;HP:0002808;HP:0001655;HP:0001270;HP:0004322;HP:0012389;HP:0010307;HP:0000405;HP:0001538;HP:0001638;HP:0000212;HP:0004887;HP:0012368;HP:0001537;HP:0001633;HP:0006467;HP:0006380;HP:0001653;HP:0001659;HP:0000388;HP:0001646;HP:0005280;HP:0000280;HP:0008936;HP:0002091;HP:0002205;HP:0002540;HP:0011359;HP:0001712;HP:0001762;HP:0002213;HP:0002465;HP:0001433;HP:0000286;HP:0011314;HP:0001744;HP:0005487;HP:0000023;HP:0002474;HP:0007421;HP:0010444;HP:0001609;HP:0011364;HP:0001363	Lower thoracic interpediculate narrowness;Severe postnatal growth retardation;Osteopenia;Hypertrophic cardiomyopathy;Recurrent otitis media;Palpebral edema;Large sella turcica;Wide intermamillary distance;Progressive alveolar ridge hypertropy;Narrow forehead;Long philtrum;Increased serum beta-hexosaminidase;Talipes equinovarus;Flared iliac wings;Ovoid vertebral bodies;Protuberant abdomen;Short long bone;Heart murmur;Abnormality of the rib cage;Severe global developmental delay;Hoarse voice;Thickened calvaria;Opacification of the corneal stroma;Thoracolumbar kyphoscoliosis;Split hand;Deficiency of N-acetylglucosamine-1-phosphotransferase;Megalocornea;Cardiomegaly;Congestive heart failure;Umbilical hernia;Epicanthus;Hypoplastic scapulae;Global developmental delay;Macroglossia;Anteverted nares;Carpal bone hypoplasia;Hip dislocation;Myelopathy;Beaking of vertebral bodies T12-L3;Autosomal recessive inheritance;Mucopolysacchariduria;Bullet-shaped phalanges of the hand;Diastasis recti;Recurrent bronchitis;Hepatomegaly;Increased serum iduronate sulfatase level;Depressed nasal bridge;Failure to thrive;Neonatal hypotonia;Sparse and thin eyebrow;High forehead;Coarse facial features;Atlantoaxial dislocation;Splenomegaly;Metaphyseal widening;Flat acetabular roof;Pathologic fracture;Death in childhood;Hypoplasia of the odontoid process;Inguinal hernia;Varus deformity of humeral neck;Cavernous hemangioma;Recurrent pneumonia;Aortic regurgitation;Specific learning disability;Scoliosis;Split hand;Short long bone;Hyperopic astigmatism;Carpal bone hypoplasia;Short ribs;Constrictive median neuropathy;Opacification of the corneal stroma;Irregular carpal bones;Increased serum beta-hexosaminidase;Retinopathy;Retinal degeneration;Mandibular prognathia;Aortic regurgitation;J-shaped sella turcica;Intellectual disability;Coarse facial features;Craniosynostosis;Deficiency of N-acetylglucosamine-1-phosphotransferase;Soft tissue swelling of interphalangeal joints;Shallow acetabular fossae;Dysostosis multiplex;Thickened skin;Autosomal recessive inheritance;Broad ribs;Short stature;Increased serum iduronate sulfatase level;Diastasis recti;Limited wrist movement;Obstructive sleep apnea;Narrow chest;Decreased movement range in interphalangeal joints;Hip dislocation;Shallow orbits;Oligohydramnios;Hip contracture;Cognitive impairment;Thickened skin;Gastrostomy tube feeding in infancy;Abnormality of the thoracic cavity;Sensorineural hearing impairment;Weight loss;Restricted chest movement;Postnatal growth retardation;Kyphosis;Patent foramen ovale;Motor delay;Short stature;Appendicular hypotonia;Stridor;Conductive hearing impairment;Protuberant abdomen;Cardiomyopathy;Gingival overgrowth;Respiratory failure requiring assisted ventilation;Flat face;Umbilical hernia;Abnormal mitral valve morphology;Limited shoulder movement;Knee flexion contracture;Mitral regurgitation;Aortic regurgitation;Otitis media;Abnormal aortic valve morphology;Depressed nasal bridge;Coarse facial features;Muscular hypotonia of the trunk;Restrictive ventilatory defect;Recurrent respiratory infections;Inability to walk;Dry hair;Left ventricular hypertrophy;Talipes equinovarus;Fine hair;Poor speech;Hepatosplenomegaly;Epicanthus;Abnormality of long bone morphology;Splenomegaly;Prominent metopic ridge;Inguinal hernia;Expressive language delay;Telangiectases of the cheeks;Pulmonary insufficiency;Hoarse voice;White hair;Craniosynostosis	.	.	.	Expressed in the heart, whole brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:16120602}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	intestine;pharynx;skin;stomach;lacrimal gland;testis;unclassifiable (Anatomical System);larynx;kidney;uterus;whole body;pancreas;head and neck;mammary gland;spinal cord;skeletal muscle;islets of Langerhans;cervix;spleen;liver;cartilage;endometrium;bone;gall bladder;parathyroid;brain;blood;heart;bone marrow;lung;salivary gland;cerebral cortex;ovary;bladder;frontal lobe;sympathetic chain;colon;placenta;aorta;prostate;nasopharynx;breast;	ciliary ganglion;caudate nucleus;pons;amygdala;fetal brain;occipital lobe;prefrontal cortex;cingulate cortex;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	8.96E-02	N	N	N	N	0.432931909928947	N	Gnptab	respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; 	gnptab	osteoblast	decreased amount	abnormal	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chr12	101796910	.	T	TGACTGGCCGTC	1471.6	FS200	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=3;AS_FS=222.005;AS_MQ=60;AS_MQRankSum=0;AS_QD=2.8;AS_ReadPosRankSum=5.6;AS_SOR=11.226;BaseQRankSum=3.07;DP=530;ExcessHet=3.0103;FS=222.005;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=2.8;ReadPosRankSum=5.63;SOR=11.226	GT:AD:DP:GQ:PGT:PID:PL:PS	0|1:252,273:525:99:0|1:101796904_A_G:1479,0,5583:101796904
chrX	139532512	139532512	T	C	F9	intronic	.	.	.	0.7927	GnomAdGenome_AF_amr	NA	NA	hom	645	17279.1	PASS	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.6417	0.7927	0.642384	0.0	0.54476	0.0		0.0					chrX	139532512	.	T	C	17279.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=26.79;AS_ReadPosRankSum=.;AS_SOR=0.828;DP=657;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=26.79;SOR=0.828	GT:AD:DP:GQ:PL	1/1:0,645:645:99:17293,1924,0
chrX	139535357	139535357	A	-	F9	intronic	.	.	.	0.0583	GnomAdGenome_AF_afr	NA	NA	het	488	215.6	QD2	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0178	0.0583	0.0	0.0	0.000461	0.0		0.0					chrX	139535356	.	CA	C	215.6	QD2	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1.5;AS_FS=1.723;AS_MQ=60;AS_MQRankSum=0.3;AS_QD=0.46;AS_ReadPosRankSum=1.3;AS_SOR=0.646;BaseQRankSum=1.16;DP=546;ExcessHet=3.0103;FS=1.569;MLEAC=1;MLEAF=0.5;MQ=59.82;MQRankSum=0.438;QD=0.46;ReadPosRankSum=1.96;SOR=0.659	GT:AD:DP:GQ:PL	0/1:411,60:488:99:223,0,10652
chrX	139540095	139540095	T	C	F9	intronic	.	.	.	0.9362	GnomAdGenome_AF_asj	NA	NA	hom	430	12718.1	PASS	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.8801	0.9362	0.805033	0.0	0.0004226	0.0		0.0					chrX	139540095	.	T	C	12718.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=29.58;AS_ReadPosRankSum=.;AS_SOR=0.78;DP=451;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=29.58;SOR=0.78	GT:AD:DP:GQ:PL	1/1:0,430:430:99:12732,1288,0
chrX	139549056	139549056	G	A	F9	intronic	.	.	.	0.9783	GnomAdGenome_AF_afr	NA	NA	hom	315	8597.06	PASS	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.9451	0.9783	0.903046	0.0	0.713578	0.0		0.0					chrX	139549056	.	G	A	8597.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=-1.7;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=27.29;AS_ReadPosRankSum=0.1;AS_SOR=0.244;BaseQRankSum=-1.683;DP=337;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=27.29;ReadPosRankSum=0.11;SOR=0.244	GT:AD:DP:GQ:PL	1/1:1,314:315:99:8611,901,0
chrX	139553813	139553814	AA	-	F9	intronic	.	.	.	0.0079	GnomAdGenome_AF_fin	NA	NA	het	67	367.6	PASS	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0004	0.0079	0.0	0.0	0.0	0.0		0.0					chrX	139553812	.	CAA	C	367.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=2.2;AS_FS=4.709;AS_MQ=57.06;AS_MQRankSum=-1.9;AS_QD=2.44;AS_ReadPosRankSum=-1;AS_SOR=2.101;BaseQRankSum=1.94;DP=125;ExcessHet=3.0103;FS=1.194;MLEAC=1;MLEAF=0.5;MQ=58.42;MQRankSum=-1.402;QD=11.49;ReadPosRankSum=-0.59;SOR=0.498	GT:AD:DP:GQ:PL	0/1:17,15:67:99:375,0,1063
chrX	139553844	139553844	A	-	F9	intronic	.	.	.	0.137748	1000g2015aug_all	NA	NA	het	96	316.6	PASS	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0436	0.1351	0.137748	0.0	0.000461	0.0		0.0					chrX	139553843	.	TA	T	316.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=1;AS_FS=17.181;AS_MQ=60;AS_MQRankSum=1.8;AS_QD=1.05;AS_ReadPosRankSum=0.1;AS_SOR=2.952;BaseQRankSum=1.42;DP=154;ExcessHet=3.0103;FS=19.191;MLEAC=1;MLEAF=0.5;MQ=59.05;MQRankSum=2.71;QD=4.95;ReadPosRankSum=0.488;SOR=2.569	GT:AD:DP:GQ:PL	0/1:40,24:96:99:324,0,914
chrX	139559529	139559529	A	-	F9	intronic	.	.	.	0.0523	GnomAdGenome_AF_afr	NA	NA	het	154	1043.6	PASS	.	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	.	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.018	0.0523	0.0394702	0.0	0.00073	0.0		0.0					chrX	139559528	.	CA	C	1043.6	PASS	AC=1;AF=0.5;AN=2;AS_BaseQRankSum=-0.1;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=6.41;AS_ReadPosRankSum=-0.6;AS_SOR=0.758;BaseQRankSum=-0.083;DP=199;ExcessHet=3.0103;FS=0.591;MLEAC=1;MLEAF=0.5;MQ=60;MQRankSum=0;QD=8.15;ReadPosRankSum=0.204;SOR=0.756	GT:AD:DP:GQ:PL	0/1:80,48:154:99:1051,0,1850
chrX	139561980	139561980	G	A	F9	exonic	nonsynonymous SNV	.	F9:NM_001313913:exon7:c.G1181A:p.G394D,F9:NM_000133:exon8:c.G1295A:p.G432D	0.0	GnomAdExome_AF	NA	NA	hom	227	6431.06	PASS	26.4	[MIM:306900]Hemophilia B;[MIM:300807]Thrombophilia, X-linked, due to factor IX defect;	300746	Uncertain significance	Mild hemophilia B;Moderately severe hemophilia B;Severe hemophilia B;Symptomatic form of hemophilia B in female carriers	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	.	HP:0001871;HP:0001939;HP:0000006;HP:0001417;HP:0002625;HP:0100724;HP:0010989;HP:0002239;HP:0002758;HP:0003645;HP:0011858;HP:0005542;HP:0005261;HP:0001419;HP:0001892;HP:0001934	Abnormality of blood and blood-forming tissues;Abnormality of metabolism/homeostasis;Autosomal dominant inheritance;X-linked inheritance;Deep venous thrombosis;Hypercoagulability;Abnormality of the intrinsic pathway;Gastrointestinal hemorrhage;Osteoarthritis;Prolonged partial thromboplastin time;Reduced factor IX activity;Prolonged whole-blood clotting time;Joint hemorrhage;X-linked recessive inheritance;Abnormal bleeding;Persistent bleeding after trauma	.	.	.	Detected in blood plasma (at protein level) (PubMed:3857619, PubMed:8295821, PubMed:2592373, PubMed:9169594, PubMed:19846852). Synthesized primarily in the liver and secreted in plasma. {ECO:0000269|PubMed:19846852, ECO:0000269|PubMed:2592373, ECO:0000269|PubMed:3857619}.;	D	D	D	D	D	D	M	D	D	D	D	D	D	T	D	D	D	T	.;.;	D	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain;.	.	.	Medium	Medium	Medium	liver;unclassifiable (Anatomical System);	liver;superior cervical ganglion;trigeminal ganglion;skin;fetal liver;	.	E	N	N	N	0.696870527160482	E	F9	homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 	.	.	.	.	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0					chrX	139561980	.	G	A	6431.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.33;AS_ReadPosRankSum=.;AS_SOR=0.794;DP=241;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.33;SOR=0.794	GT:AD:DP:GQ:PL	1/1:0,227:227:99:6445,677,0
chrX	154531643	154531643	C	T	G6PD	UTR3	.	NM_000402:c.*357G>A;NM_001360016:c.*357G>A;NM_001042351:c.*357G>A	.	0.9182	GnomAdGenome_AF_fin	NA	NA	hom	312	8755.06	PASS	.	[MIM:300908]Anemia, non-spherocytic hemolytic, due to G6PD deficiency;	305900	.	Class I glucose-6-phosphate dehydrogenase deficiency	Disease-causing germline mutation(s) in	Mean corpuscular volume[28453575;28453575];Mean corpuscular hemoglobin[28453575];Red blood cell traits[23696099;23696099;23696099;23446634;23446634;23446634;23446634;23446634];Glycated hemoglobin levels[28898252];Hemoglobin levels[26366553];Red blood cell count[28453575];Bilirubin levels[19419973];Red cell distribution width[28453575];Iron status biomarkers (transferrin saturation)[28334935];	HP:0002027;HP:0001923;HP:0001974;HP:0001945;HP:0000980;HP:0001744;HP:0001419;HP:0004447;HP:0008282;HP:0011273;HP:0004814;HP:0003641;HP:0001423;HP:0006579;HP:0020082	Abdominal pain;Reticulocytosis;Leukocytosis;Fever;Pallor;Splenomegaly;X-linked recessive inheritance;Poikilocytosis;Unconjugated hyperbilirubinemia;Anisocytosis;Fava bean-induced hemolytic anemia;Hemoglobinuria;X-linked dominant inheritance;Prolonged neonatal jaundice;Heinz bodies	.	.	.	Isoform Long is found in lymphoblasts, granulocytes and sperm.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;cornea;spinal ganglion;skin;stomach;testis;pituitary gland;lens;lymphoreticular;unclassifiable (Anatomical System);cerebellum;choroid;kidney;uterus;retina;pancreas;mammary gland;skeletal muscle;visual apparatus;tonsil;cervix;fovea centralis;spleen;liver;cartilage;endometrium;bone;germinal center;brain;blood;heart;bone marrow;trabecular meshwork;lung;salivary gland;ovary;macula lutea;lymph node;oesophagus;colon;placenta;prostate;breast;optic nerve;hypothalamus;medulla oblongata;	testis - seminiferous tubule;adipose tissue;whole blood;testis;	1.69E-02	E	N	E	N	0.987245268640729	E	G6pdx	cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 	g6pd	nucleate erythrocyte	decreased amount	abnormal	0.0	0.0	0.0	0.6316	0.9182	0.0	0.0	6.5e-06	0.0		0.0					chrX	154531643	.	C	T	8755.06	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=28.06;AS_ReadPosRankSum=.;AS_SOR=0.873;DP=324;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=28.06;SOR=0.873	GT:AD:DP:GQ:PL	1/1:0,312:312:99:8769,925,0
chrX	154532293	154532293	G	A	G6PD	intronic	.	.	.	0.9205	GnomAdGenome_AF_fin	NA	NA	hom	410	11407.1	PASS	.	[MIM:300908]Anemia, non-spherocytic hemolytic, due to G6PD deficiency;	305900	.	Class I glucose-6-phosphate dehydrogenase deficiency	Disease-causing germline mutation(s) in	Mean corpuscular volume[28453575;28453575];Mean corpuscular hemoglobin[28453575];Red blood cell traits[23696099;23696099;23696099;23446634;23446634;23446634;23446634;23446634];Glycated hemoglobin levels[28898252];Hemoglobin levels[26366553];Red blood cell count[28453575];Bilirubin levels[19419973];Red cell distribution width[28453575];Iron status biomarkers (transferrin saturation)[28334935];	HP:0002027;HP:0001923;HP:0001974;HP:0001945;HP:0000980;HP:0001744;HP:0001419;HP:0004447;HP:0008282;HP:0011273;HP:0004814;HP:0003641;HP:0001423;HP:0006579;HP:0020082	Abdominal pain;Reticulocytosis;Leukocytosis;Fever;Pallor;Splenomegaly;X-linked recessive inheritance;Poikilocytosis;Unconjugated hyperbilirubinemia;Anisocytosis;Fava bean-induced hemolytic anemia;Hemoglobinuria;X-linked dominant inheritance;Prolonged neonatal jaundice;Heinz bodies	not_provided	criteria_provided,_single_submitter	Benign	Isoform Long is found in lymphoblasts, granulocytes and sperm.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;cornea;spinal ganglion;skin;stomach;testis;pituitary gland;lens;lymphoreticular;unclassifiable (Anatomical System);cerebellum;choroid;kidney;uterus;retina;pancreas;mammary gland;skeletal muscle;visual apparatus;tonsil;cervix;fovea centralis;spleen;liver;cartilage;endometrium;bone;germinal center;brain;blood;heart;bone marrow;trabecular meshwork;lung;salivary gland;ovary;macula lutea;lymph node;oesophagus;colon;placenta;prostate;breast;optic nerve;hypothalamus;medulla oblongata;	testis - seminiferous tubule;adipose tissue;whole blood;testis;	1.69E-02	E	N	E	N	0.987245268640729	E	G6pdx	cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 	g6pd	nucleate erythrocyte	decreased amount	abnormal	0.0	0.0	0.0	0.6328	0.9205	0.0	0.0	0.0231174	0.0		0.0					chrX	154532293	.	G	A	11407.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.82;AS_ReadPosRankSum=.;AS_SOR=0.713;DP=415;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.82;SOR=0.713	GT:AD:DP:GQ:PL	1/1:0,410:410:99:11421,1222,0
chrX	154532439	154532439	A	G	G6PD	exonic	synonymous SNV	.	G6PD:NM_000402:exon11:c.T1401C:p.Y467Y,G6PD:NM_001042351:exon11:c.T1311C:p.Y437Y,G6PD:NM_001360016:exon11:c.T1311C:p.Y437Y	0.9258	GnomAdGenome_AF_fin	NA	NA	hom	492	13289.1	PASS	.	[MIM:300908]Anemia, non-spherocytic hemolytic, due to G6PD deficiency;	305900	.	Class I glucose-6-phosphate dehydrogenase deficiency	Disease-causing germline mutation(s) in	Mean corpuscular volume[28453575;28453575];Mean corpuscular hemoglobin[28453575];Red blood cell traits[23696099;23696099;23696099;23446634;23446634;23446634;23446634;23446634];Glycated hemoglobin levels[28898252];Hemoglobin levels[26366553];Red blood cell count[28453575];Bilirubin levels[19419973];Red cell distribution width[28453575];Iron status biomarkers (transferrin saturation)[28334935];	HP:0002027;HP:0001923;HP:0001974;HP:0001945;HP:0000980;HP:0001744;HP:0001419;HP:0004447;HP:0008282;HP:0011273;HP:0004814;HP:0003641;HP:0001423;HP:0006579;HP:0020082	Abdominal pain;Reticulocytosis;Leukocytosis;Fever;Pallor;Splenomegaly;X-linked recessive inheritance;Poikilocytosis;Unconjugated hyperbilirubinemia;Anisocytosis;Fava bean-induced hemolytic anemia;Hemoglobinuria;X-linked dominant inheritance;Prolonged neonatal jaundice;Heinz bodies	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_single_submitter	Benign	Isoform Long is found in lymphoblasts, granulocytes and sperm.;	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;cornea;spinal ganglion;skin;stomach;testis;pituitary gland;lens;lymphoreticular;unclassifiable (Anatomical System);cerebellum;choroid;kidney;uterus;retina;pancreas;mammary gland;skeletal muscle;visual apparatus;tonsil;cervix;fovea centralis;spleen;liver;cartilage;endometrium;bone;germinal center;brain;blood;heart;bone marrow;trabecular meshwork;lung;salivary gland;ovary;macula lutea;lymph node;oesophagus;colon;placenta;prostate;breast;optic nerve;hypothalamus;medulla oblongata;	testis - seminiferous tubule;adipose tissue;whole blood;testis;	1.69E-02	E	N	E	N	0.987245268640729	E	G6pdx	cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 	g6pd	nucleate erythrocyte	decreased amount	abnormal	0.0	0.0	0.0	0.8318	0.9258	0.0	0.0	0.0232662	0.0		0.0					chrX	154532439	.	A	G	13289.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=.;AS_FS=0;AS_MQ=60;AS_MQRankSum=.;AS_QD=27.01;AS_ReadPosRankSum=.;AS_SOR=0.718;DP=503;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;QD=27.01;SOR=0.718	GT:AD:DP:GQ:PL	1/1:0,492:492:99:13303,1469,0
chrX	154534419	154534419	G	A	G6PD	exonic	nonsynonymous SNV	.	G6PD:NM_000402:exon6:c.C653T:p.S218F,G6PD:NM_001042351:exon6:c.C563T:p.S188F,G6PD:NM_001360016:exon6:c.C563T:p.S188F	0.075099	GME_AP	3.0	NA	hom	463	12978.1	PASS	23.6	[MIM:300908]Anemia, non-spherocytic hemolytic, due to G6PD deficiency;	305900	Uncertain significance	Class I glucose-6-phosphate dehydrogenase deficiency	Disease-causing germline mutation(s) in	Mean corpuscular volume[28453575;28453575];Mean corpuscular hemoglobin[28453575];Red blood cell traits[23696099;23696099;23696099;23446634;23446634;23446634;23446634;23446634];Glycated hemoglobin levels[28898252];Hemoglobin levels[26366553];Red blood cell count[28453575];Bilirubin levels[19419973];Red cell distribution width[28453575];Iron status biomarkers (transferrin saturation)[28334935];	HP:0002027;HP:0001923;HP:0001974;HP:0001945;HP:0000980;HP:0001744;HP:0001419;HP:0004447;HP:0008282;HP:0011273;HP:0004814;HP:0003641;HP:0001423;HP:0006579;HP:0020082	Abdominal pain;Reticulocytosis;Leukocytosis;Fever;Pallor;Splenomegaly;X-linked recessive inheritance;Poikilocytosis;Unconjugated hyperbilirubinemia;Anisocytosis;Fava bean-induced hemolytic anemia;Hemoglobinuria;X-linked dominant inheritance;Prolonged neonatal jaundice;Heinz bodies	G6PD_CAGLIARI|G6PD_MEDITERRANEAN|G6PD_SASSARI|G6PD_deficient_hemolytic_anemia|Hemolytic_anemia,_G6PD_deficient_(favism)|Glucose_6_phosphate_dehydrogenase_deficiency|Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency|Susceptibility_to_malaria|Angioedema_induced_by_ACE_inhibitors,_susceptibility_to|Inborn_genetic_diseases|not_provided	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Isoform Long is found in lymphoblasts, granulocytes and sperm.;	D	D	B	B	D	D	M	D	D	D	D	T	.	T	D	D	T	D	.;.;.;.;.;.;.;	D	.	Glucose-6-phosphate dehydrogenase, NAD-binding;Glucose-6-phosphate dehydrogenase, NAD-binding;Glucose-6-phosphate dehydrogenase, NAD-binding;.;Glucose-6-phosphate dehydrogenase, NAD-binding;Glucose-6-phosphate dehydrogenase, NAD-binding;Glucose-6-phosphate dehydrogenase, NAD-binding	.	.	Medium	Medium	Medium	thymus;intestine;pharynx;cornea;spinal ganglion;skin;stomach;testis;pituitary gland;lens;lymphoreticular;unclassifiable (Anatomical System);cerebellum;choroid;kidney;uterus;retina;pancreas;mammary gland;skeletal muscle;visual apparatus;tonsil;cervix;fovea centralis;spleen;liver;cartilage;endometrium;bone;germinal center;brain;blood;heart;bone marrow;trabecular meshwork;lung;salivary gland;ovary;macula lutea;lymph node;oesophagus;colon;placenta;prostate;breast;optic nerve;hypothalamus;medulla oblongata;	testis - seminiferous tubule;adipose tissue;whole blood;testis;	1.69E-02	E	N	E	N	0.987245268640729	E	G6pdx	cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 	g6pd	nucleate erythrocyte	decreased amount	abnormal	0.0026	0.0173	0.0207	0.0005	0.0144	0.000794702	0.0007	0.0024838	0.000998	PASS	0.075099	0.005396	3.0			chrX	154534419	.	G	A	12978.1	PASS	AC=2;AF=1;AN=2;AS_BaseQRankSum=0.2;AS_FS=0;AS_MQ=60;AS_MQRankSum=0;AS_QD=28.03;AS_ReadPosRankSum=1.2;AS_SOR=0.779;BaseQRankSum=0.289;DP=469;ExcessHet=3.0103;FS=0;MLEAC=2;MLEAF=1;MQ=60;MQRankSum=0;QD=28.03;ReadPosRankSum=1.2;SOR=0.779	GT:AD:DP:GQ:PL	1/1:2,461:463:99:12992,1335,0
